Magnetic resonance imaging of the cerebral metabolic rate of oxygen (CMRO₂) by Bolar, Divya Sanam
Magnetic Resonance Imaging of the  
Cerebral Metabolic Rate of Oxygen (CMRO2) 
by 
Divya Sanam Bolar 
B.S. Biomedical Engineering 
Johns Hopkins University, 2000 
B.S. Electrical Engineering 
Johns Hopkins University, 2000 
S.M. Electrical Engineering and Computer Science  
Massachusetts Institute of Technology, 2007 
 
SUBMITTED TO THE HARVARD-MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY IN 
PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF 
 
DOCTOR OF PHILOSOPHY IN ELECTRICAL AND BIOMEDICAL ENGINEERING 
AT THE 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 
 
JANUARY 2010 
 
© 2010 Massachusetts Institute of Technology.  All rights reserved. 
 
 
 
Signature of Author: __________________________________________________________ 
Harvard-MIT Division of Health Sciences and Technology 
January 21st, 2010 
 
Certified by: _________________________________________________________________ 
Elfar Adalsteinsson, Ph.D. 
Associate Professor of Electrical and Engineering 
Associate Professor of Health Sciences and Technology 
 
Accepted by: ________________________________________________________________ 
Ram Sasisekharan, Ph.D. 
Director, Harvard-MIT Division of Health Sciences and Technology 
Edward Hood Taplin Professor of Health Sciences & Technology and Biological Engineering 
  
2
  
3
Magnetic Resonance Imaging of the  
Cerebral Metabolic Rate of Oxygen (CMRO2) 
by 
Divya Sanam Bolar 
Submitted to the Harvard-MIT Division of Health Sciences and Technology 
on January 21, 2010 in Partial Fulfillment of the Requirements for the Degree of 
Doctor of Philosophy in Electrical and Biomedical Engineering 
Abstract 
Oxygen consumption is an essential process of the functioning brain.  The rate at which the 
brain consumes oxygen is known as the cerebral metabolic rate of oxygen (CMRO2). CMRO2 
is intimately related to brain health and function, and will change in settings of disease and 
functional activation. Accurate CMRO2 measurement will enable detailed investigation of 
neuropathology and facilitate our understanding of the brain’s underlying functional 
architecture.     
Despite the importance of CMRO2 in both clinical and basic neuroscience settings, a robust 
CMRO2 mapping technique amenable to functional and clinical MRI has not been 
established.  To address this issue, a novel method called QUantitative Imaging of eXtraction 
of Oxygen and TIssue Consumption, or QUIXOTIC, is introduced.  The key innovation in 
QUIXOTIC is the use of velocity-selective spin labeling to isolate MR signal exclusively from 
post-capillary venular blood on a voxel-by-voxel basis. This isolated signal can be related to 
venular oxygen saturation, oxygen extraction fraction, and ultimately CMRO2.  
This thesis first explores fundamental theory behind the QUIXOTIC technique, including 
design of a novel MRI pulse sequence, explanation of the principal sequence parameters, 
and results from initial human experiences.  A human trial follows, in which QUIXOTIC is 
used to measure cortical gray matter CMRO2 in ten healthy volunteers.  QUIXOTIC-measured 
CMRO2 is found to be within the expected physiological range and is comparable to values 
reported by other techniques.  QUIXOTIC is then applied to evaluate CMRO2 response to 
carbon-dioxide-induced hypercapnia in awake humans. In this study, CMRO2 is observed to 
decrease in response to mild hypercapnia. Finally, pilot studies that show feasibility of 
QUIXOTIC-based functional MRI (fMRI) and so-called “turbo” QUIXOTIC are presented and 
discussed.     
Thesis Supervisor: Elfar Adalsteinsson, PhD 
Title: Associate Professor of Electrical Engineering and Computer Science and Harvard-MIT 
Division of Health Sciences and Technology  
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Introduction 
Energy is necessary to maintain fundamental processes of cellular function.  In the brain, the 
processes that consume the majority of energy involve transmission and reception of 
electrical impulses through cells called neurons (1).  Signaling through these neurons enables 
thought, action, and consciousness, and is critical for proper brain function.  As such, status 
of energy production is a key indicator of brain health, and measuring related parameters is 
an important goal of clinical and neural science.   
The primary source of free energy in all living cells is adenosine triphosphate or ATP.  
Metabolic pathways of ATP production have been well studied, and the most efficient and 
common way to produce ATP involves the reduction of oxygen to form water.  Monitoring 
the rate of this oxygen consumption therefore provides a way to assess energy production, 
and more indirectly, neural activity.  The rate at which the brain consumes oxygen is known 
as the cerebral metabolic rate of oxygen (CMRO2).   Closely related to CMRO2 is the oxygen 
extraction fraction (OEF).  OEF quantifies the ratio of oxygen consumption to oxygen 
delivery.  Since oxygen is primarily supplied via incoming blood flow from cerebral arteries, 
OEF represents the amount of oxygen that leaves the blood stream to supply the 
surrounding tissue (2). 
Estimates of CMRO2 and OEF in humans have been made for over the past fifty years.  In 
1945, Kety and Schmidt measured the rate of nitrous oxide uptake in the brain and blood 
oxygen concentrations in vessels supplying and draining the brain to estimate CMRO2 and 
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OEF (3,4).  While pioneering work, these experiments were highly invasive, requiring femoral 
artery and jugular vein punctures, and offered only global estimates.  A major breakthrough 
for assessing brain oxygen metabolism came in the 1970’s in the form of positron emission 
tomography (PET) technology.  Imaging via PET generates maps of CMRO2 and OEF in vivo, 
allowing dynamic, regional information about these two parameters.  Since then, PET has 
been used with success and has become the default technique to image CMRO2 and OEF in 
clinical and functional neuroscience settings.   
Despite its accomplishments, PET imaging has many limitations.  Image resolution tends 
to be low, an on-site cyclotron is required to create radioisotopes needed for CMRO2 
imaging, and importantly, PET requires exposure to potentially harmful radioactive 
materials.  Because of these reasons, there are only a few hundred PET scanners in the world 
(283 as of 2001, (5)), and even fewer routinely image CMRO2.  Furthermore, PET relies on 
indirect measures of OEF and CBF to estimate CMRO2. 
In contrast to the PET, magnetic resonance imaging (MRI) is safe and non-invasive, does 
not require injection of exogenous agents, and is ubiquitously available throughout the 
developed world.  MRI offers a new platform to image CMRO2 and OEF, but to date, imaging 
and quantifying these physiological parameters has been extremely limited and difficult.  
However, one of the major strengths of MRI is the ability to generate new contrast 
mechanisms based on creative manipulation of the so-called MRI “pulse sequence”; i.e., the 
instruction set that controls the magnetic fields and radiofrequency pulses required for MR 
imaging. 
This thesis dissertation presents a novel MRI pulse sequence (and associated methods) 
for non-invasively imaging CMRO2 and OEF in humans.  This technique has specific 
advantages over current approaches, and features regional quantification and time-course 
image generation necessary for functional neuroimaging.  The approach is dubbed 
QUantitative Imaging of eXtraction of Oxygen and TIssue Consumption, or QUXOTIC.   
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Chapter 1 of this dissertation defines CMRO2 and OEF in qualitative and quantitative 
terms, describes the utility of measuring the parameters in clinical and basic science settings, 
and presents a summary of current non-invasive MR methods of estimation.  Chapter 2 
describes in detail the theory, methods, and sequence design behind the QUIXOTIC 
technique.  Chapter 3 presents a validation study in healthy human subjects that has been 
submitted to Magnetic Resonance in Medication for publication.  Chapter 4 presents a study 
applying QUIXOTIC to determine changes in CMRO2 and OEF during a carbon dioxide 
challenge in awake humans.  This chapter is in preparation for submission to Magnetic 
Resonance in Medicine.  Chapter 5 describes current, ongoing work to 1) assess QUIXOTIC 
feasibility for functional MRI and 2) enhance QUIXOTIC efficiency by modifying the original 
pulse sequence.  Chapter 6 postulates future work to improve QUIXOTIC, with regards to 
accuracy, applicability, and reliability.  Such refinements are deemed necessary before 
widespread use of QUIXOTIC in clinical and research settings can be realized.  
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Chapter 1  
Background and Significance 
1.1 CMRO2 and OEF in the brain 
The intimate relationship between neuronal activity and energy metabolism was 
demonstrated by pioneering work in the 1970’s and 1980’s using autoradiographic and PET 
techniques (reviewed in (6) and (7)).  While the cellular mechanisms that provide the basis of 
coupling between neural activity and energy metabolism are still under investigation, 
analysis of the brain’s energy budget has determined that over 85% of the cerebral energy 
consumption is devoted to signaling-related activities.  Even at baseline states, 47% of 
energy consumed is to maintain propagation of electrical signals through neurons known as 
action potentials, and 37% relate to communication between neurons via activity around the 
so-called “synapse”, the small intracellular space between adjacent neurons (1).   
As ATP is the standard unit of energy in the body, its expenditure is necessary for 
maintaining neurotransmission.  In the brain, ATP can be generated both aerobically (with 
oxygen) and anaerobically (without oxygen), but by far the most common and efficient 
means of production is via oxygen.  Oxygen acts a final electron acceptor in aerobic 
respiration, and without oxygen, energy production is shunted to the anaerobic pathway, 
which is over ten times less efficient.  In this scenario, energy production cannot meet the 
brain’s energy demands, highlighted by the fact oxygen deprivation will result in 
unconsciousness in a manner of minutes.  Irreversible cellular death shortly follows (2).    
Cerebral oxygen consumption occurs within the mitochondria of neuronal and glial brain 
cells.  Since oxygen is not endogenously produced by the body, it must be delivered to these 
cells.  Delivery occurs in the form blood, which has a high carrying oxygen capacity via red 
blood cells (RBCs), and is nearly fully oxygenated as it leaves the lungs and arrives at brain 
tissue beds through vessels known as arteries.  As blood passes through the smallest vessels 
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in the circulation (capillaries), the distance between red blood cells and brain cells narrows.   
The combination of small distances and oxygen concentration gradients allows oxygen to 
diffuse from high-oxygen-content RBCs to lower-oxygen-content brain tissue.  In this way, 
receiving brain cells are delivered the oxygen needed to continue energy production and 
neuronal signaling.  Subsequently, blood leaving the tissue and capillary bed is deoxygenated 
and returns to the heart via the so-called venous vasculature.  Assuming all of the oxygen 
extracted in this process is consumed by brain cells to produce ATP, Fick’s first law can be 
applied to relate CMRO2 to oxygen extraction (OEF) and oxygen delivery via cerebral blood 
flow (CBF):   
 2CMRO OEF CBF Ca= ⋅ ⋅  [1] 
where Ca is the arterial blood oxygen content.  OEF is then related to the arteriovenous 
oxygen saturation difference:  
 a v2 2
2 a
Y YSaO SvOOEF
SaO Y
−−
= =  [2] 
These very relationships were the foundation for the original nitrous-oxide-based 
experiments performed by Kety and Schmidt.  The following diagram provides a qualitative 
representation of the above equations.    
  
18
 
Figure 1-1.  CMRO2 as defined by Fick's first law
1 
1.2 Functional neuroimaging 
The advent of PET and autoradiographic technologies allowed exploration of fundamental 
relationships between neural activity, CMRO2, and CBF in ways previously not possible.  
Substantial experimental evidence demonstrated that OEF, CBF, and CMRO2 changed from 
their baseline states in response to external sensory stimulation, and linked these responses 
to neuronal activity (6-9).  These landmark studies showed that neuroimaging could be used 
to understand the relationship between regional brain processes and specific mental 
function.    
In parallel to PET advancements, developments in the field of MR relating oxygen 
saturation to the MRI signal (10-12) led to pioneering discoveries in the early 1990’s.  In 
1992, three independent groups showed that MRI could be used to indirectly and 
noninvasively assay evoked increases in functional activity via the so-called blood oxygen 
level dependent (BOLD) technique (13-15).  Functional MRI (fMRI) was born and sparked a 
                                                      
 
1 From http://training.seer.cancer.gov/anatomy/cardiovascular/blood/classification.html. This work is in the 
public domain in the United States because it is a work of the United States Federal Government under the 
terms of Title 17, Chapter 1, Section 105 of the US Code. 
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revolution in the fledgling field of functional neuroimaging.  Unlike PET, fMRI is feasible on 
conventional hospital scanners, does not require exposure to radioactive materials (or a 
nearby cyclotron to produce these materials), and in general offers an approach accessible 
to a broad scientific community.  Furthermore, fMRI features far greater spatial and 
temporal resolution compared to PET, and allows generation of image time series for 
investigation of dynamic responses and utilization of complicated experimental designs.   As 
such, due to its convenience, ease, and efficacy, fMRI been one of the fastest growing fields 
in neuroscience.     
Despite the widespread success of BOLD fMRI, its contrast is based on a single relative 
(unitless) signal that is primarily influenced by vascular changes (CBF and cerebral blood 
volume), and secondarily driven by CMRO2.   The complexity of the BOLD response makes it 
difficult to tease apart these individual physiological parameters, and uniquely measuring 
CMRO2 is extremely difficult.   
Many postulate, however, that CMRO2 is in fact more tightly coupled to neuronal 
activity than vascular responses, and is thus expected to provide a more accurate 
measurement of brain activation (often defined as the discharge of electrical currents in 
neuron ensembles (16)) from both a spatial and temporal standpoint.   
From a spatial point of view, studies have suggested that an increase in neuronal activity 
results in spatially broad blood flow response, but a tightly localized CMRO2 response 
(17,18).  The BOLD signal may be even less spatially specific than the already course CBF 
response, as it derives contrast from draining vasculature far from neuronal sites of 
activation (16). 
From a temporal point-of-view, the vascular response is thought to occur substantially 
slower than the CMRO2 response, and orders of magnitude slower than the neuronal 
response (18).  In addition to being delayed, the vascular response is also dispersed in time.  
This combination of delay and dispersion makes it difficult to pin-point events on the 
temporal axis, thus complicating study of response dynamics.     
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Finally, unlike BOLD, OEF and CMRO2 are fundamental physiological parameters.  As a 
result, absolute measures are theoretically possible.  Evaluation of absolute changes is an 
important advantage over BOLD, which can detect only relative changes in the MR signal.  
Moreover, these relative changes are dependent on baseline physiological states that can 
fluctuate for many reasons, leading to highly variable BOLD responses.  In fact, identical 
tasks performed on different days can yield very heterogeneous results, even within the 
same subject.  As a consequence, diminished power in intrasubject and intersubject group 
comparisons is inevitable with BOLD fMRI (19,20).   Recent studies, however, have suggested 
that 1) normalizing the BOLD response to the CMRO2 response may reduce intrasubject 
variability (21), and 2) normalizing the BOLD response to baseline OEF may reduce 
intersubject variability (22).   In this way, measures of CMRO2 and OEF may be useful in 
increasing statistical power and reproducibility of fMRI.  
For these many reasons, imaging CMRO2 should increase precision and accuracy of 
mapping brain functional architecture, augment our understanding of how functional 
systems are connected, and allow greater insight into how neural events unfold over time. 
Imaging CMRO2 is therefore of great interest to the functional imaging community.  
1.3 Clinical application 
From a clinical standpoint, maintaining a threshold CMRO2 is critical for brain health and 
function and an important indicator of tissue integrity (23).  PET studies of CMRO2 and OEF 
have shown importance in settings of acute stroke by identifying regions known as “ischemic 
penumbra”; i.e., regions at risk of infarction, yet still with the potential to recover (24).  
While routine MRI techniques (e.g. diffusion and perfusion imaging) attempt to identify the 
penumbra, recent evidence suggests that they may not be as accurate as CMRO2 evaluation 
(25).  Brain tumor imaging studies have also been illuminating, revealing a complex 
relationship between tumor blood flow and tumor oxygen metabolism (26-29), and it is 
postulated that different tumor flow/metabolism ratios can result in largely different 
outcomes (30).  Neurodegenerative disorders also show marked changes in OEF and CMRO2.  
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PET studies of Alzheimer’s disease have shown decreased CMRO2 in areas such as the medial 
temporal lobe, despite preserved CBF (31).  PET imaging of Parkinson’s disease patients is 
currently being investigated to understand the underlying mechanisms of deep brain 
stimulation (DBS) therapy; initial studies suggest that CBF changes can identify immediate 
downstream targets of DBS, but may not reveal the brain regions that have functionally 
changed with improved motor capability (32).  Consequently, imaging CMRO2 in this setting 
may prove productive and insightful.  
The emergent field of pharmaceutical MRI (phMRI) will substantially benefit from 
CMRO2-based approaches.  phMRI uses fMRI techniques to elucidate effects of drugs that 
act within the central nervous system (CNS) and directly modulate regional neuronal activity 
(33).  phMRI holds great potential to increase our understanding of these psychotropic 
drugs, especially with regards to pharmacokinetics and dose-dependence.  BOLD fMRI, 
however, provides a mixture of vascular and metabolic contrast, with no clean way of 
separating the two.  Since many drugs (e.g. caffeine, (34)) will modulate both aspects of 
physiology, BOLD alone is incapable of disambiguating vascular responses to a 
pharmacological challenge, from neural responses, making it difficult to understand the CNS-
modulating effects of the drug (35). BOLD is thus ill-suited for phMRI.  CMRO2, on the other 
hand, is independent of vascular changes, and can provide a metabolic measurement closely 
related to neuronal activity, avoiding confounding vascular effects.  As phMRI becomes a 
powerful technique to investigate neuronal changes by novel drugs, CMRO2 MR imaging will 
become an increasingly desirable tool (36). 
In sum, since CMRO2 and OEF are affected in many neurological disorders and may aid 
in characterizing CNS effects of new and existing drugs, evaluation with non-invasive imaging 
techniques like MRI is of crucial value.  Quantitative, spatially specific MR images of CMRO2 
and OEF will significantly improve our ability to diagnose, evaluate therapy, introduce new 
therapy, and monitor disease progression.  
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1.4 Current MRI methods for measuring OEF and CMRO2 
1.4.1 Role of deoxygenated hemoglobin 
Despite the call for CMRO2 and OEF MRI, from both a functional and clinical perspective, the 
techniques proposed to date all have significant limitations.  One of the main difficulties in 
measuring OEF and CMRO2 with proton-based MRI is the lack of a direct contrast 
mechanism.  Despite this challenge, indirect, noninvasive MRI methods for measuring OEF 
and CMRO2 do exist, and are enabled by the unique properties of the metalloprotein 
hemoglobin.  
Hemoglobin is the predominant carrier of oxygen in red blood cells of mammalian 
blood.  Within hemoglobin are iron-containing heme groups that bind oxygen with great 
affinity.  In its deoxygenated state, the heme iron occupies a high-spin state (as Fe++), due to 
a high proportion of unpaired electrons.  These unpaired electrons exhibit a strong magnetic 
moment, and thus have a strong paramagnetic property.  As such, the deoxygenated form of 
hemoglobin (deoxyhemoglobin, dHb) can dramatically perturb the magnetic field of the MRI 
scanner and lower measured MRI signals.  As heme becomes oxidized, however, these 
unpaired electrons are partially transferred to an oxygen molecule, and heme iron switches 
to a low-spin state resulting in zero magnetic moment.  Thus, this oxygenated form of 
hemoglobin (oxyhemoglobin, HbO2) is diamagnetic and does not affect the magnetic field, 
and therefore leaves the MR signal unaffected (37).  
This interesting phenomenon has been extensively studied.  The effects of dHb have 
been found to be incredibly strong, and extend beyond the hemoglobin protein, red blood 
cell, and even blood vessel.  In fact, deoxygenated blood will perturb the magnetic field far 
into the surrounding tissue, creating large field inhomogeneities that will reduce signal from 
these region as well (38). 
These phenomena have profound implications for MRI when considering the 
heterogeneous oxygen distribution in the circulation.  Blood receives oxygen from fresh air 
supplied by the lung and is fully oxygenated (i.e. nearly all molecules of hemoglobin are 
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saturated with oxygen).  This oxygenated blood is then pumped from the heart into the 
arterial circulation, where it disseminates throughout the body and perfuses organs.  Oxygen 
is transferred from hemoglobin in the blood supply to the recipient tissue via diffusion-based 
gas exchange in capillary beds.  Blood leaves these capillary beds partially deoxygenated, 
and clears through to venous circulation.  Importantly, at normal resting physiological states, 
roughly 40% of the total hemoglobin in deoxygenated venous blood is comprised of dHb 
(39). 
1.4.2 Relative methods: Calibrated BOLD 
Based on the properties of dHb and circulatory oxygen distribution, it follows that the BOLD 
signal is heavily influenced by the content of dHb on the venous side of the circulation; i.e. 
the higher the concentration of dHb, the lower the signal.  In fMRI, dHb content is primarily 
modulated by CBF, CMRO2, and cerebral blood volume (CBV); as such these physiological 
parameters are represented by the aggregate BOLD MRI signal.  As suggested in sections 1.2 
and 1.3, separating signals from individual parameters is extremely challenging.   
A significant goal of fMRI development has been to resolve CMRO2 from the BOLD 
signal.  Recently, a new “calibrated” BOLD technique has been introduced to extrapolate the 
relative CMRO2 signal (40).  Calibrated BOLD uses concurrent BOLD and CBF acquisitions to 
estimate relative BOLD and relative CBF changes, respectively, during a CMRO2-independent 
CBF challenge.  The challenge used in this technique is hypercapnia induction via CO2 
breathing.   CO2 is potent vasodilator; as such, hypercapnia causes a large increase in CBF, 
with supposedly marginal effects on neuronal activity and oxygen metabolism.  By assuming 
a power-law relationship between CBV and CBF (41), and normalizing the BOLD and CBF 
signals to this hypercapnia-induced, CMRO2-independent signal change, relative CMRO2 
during functionally related changes in neuronal activity can be estimated. 
Calibrated BOLD offers a relatively simple mathematical framework relating relative 
CBF, relative BOLD, and relative CMRO2 signals.   Additionally, it can be performed on 
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conventional MRI scanners, since BOLD and CBF pulse sequences are standard in clinical 
imaging packages.  
Several assumptions, however, are required to make the relative CMRO2 estimate, and 
some of these have recently been called under into question.  The largest assumption is that 
hypercapnia increases CBF without affecting CMRO2.  While CO2-challenge has been widely 
known to significantly increase CBF, CO2 effects on neuronal activity and oxygen metabolism 
are much less clear.  Studies over the past several years have suggested that CO2 does 
indeed alter neuronal activity; some reports suggest that CMRO2 increases during 
hypercapnia (42-44), and others suggest a CMRO2 decrease during hypercapnia (45,46).  
Since these studies have heterogeneous protocols, study designs, and results, it is clear that 
further investigation is needed to better understand the effects of hypercapnia on CMRO2 
and subsequent implications for the calibrated BOLD technique.  In addition, new studies 
have uncovered other sources of systematic bias in calibrated BOLD, based on the regional 
variation of the key calibration constant (47-49), and the assumption of a fixed power-law 
relationship between CBF and CBV (50,51). 
In sum, calibrated BOLD offers a simple way to estimate relative CMRO2 amenable to 
standard functional imaging protocols.   However, since calibrated BOLD can only assess 
CRMO2 changes in response to a stimulus, its utility in clinical settings is diminished.  In 
settings of diseases like stroke and tumor, absolute values in both healthy and disease states 
across populations are of greatest value.  Additionally, as mentioned, key assumptions 
required for calibrated BOLD have been recently challenged (42-44),(45,46).  Based on these 
arguments, calibrated BOLD may be a less than ideal approach for measuring CMRO2.  
1.4.3 Absolute methods 
Because of the limitations in using relative methods to calculate CMRO2, several 
investigations have attempted to resolve absolute CMRO2 from the MRI signal.  These 
approaches also exploit the effects of dHb on the MRI signal, and in this way specifically 
measure oxygen saturation in venous blood (Yv).  With an additional assumption or non-MRI 
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measure of Ya, OEF can be calculated via equation [2].  In healthy individuals, arterial blood is 
nearly fully saturated throughout the arterial circulation (i.e. Ya = 1), since gas exchange is 
thought to only commence when oxygenated blood reaches capillary beds.  In reality, Ya is 
slightly less than 1, about 0.98 or 0.99 in normal baseline physiological state, which can be 
readily measured with pulse oximetry.  Following OEF calculation, a more detailed form of 
equation [1] can be used to calculate CMRO2: 
 [ ]2 total aCMRO OEF CBF Ca OEF CBF Hb Y= ⋅ ⋅ = ⋅ ⋅ ⋅  [3] 
where [Hbtotal] is the total concentration of hemoglobin in blood and is related to hematocrit 
in the following fashion: 
 [ ]total HctHb 3.0 (ml/g) 0.016125 (g/ȝmol)= ⋅  [4] 
CBF can be measured by independent MRI methods such as ASL or dynamic-susceptibility 
contrast (DSC).  Hematocrit can be assumed or easily measured from a drop of blood 
obtained via finger prick.   
The challenge in estimating OEF and CMRO2 is thus to first measure cerebral Yv.   Three 
broad classes exist for measuring cerebral Yv from the MRI signal: 
1. Phase-based susceptibility methods 
2. Extravascular T2’ based methods 
3. Intravascular T2 based methods 
1.4.3.1 Phase-based susceptibility methods to estimate Yv 
Phase-based susceptibility methods employ phase contrast imaging to examine magnetic 
susceptibility differences between veins and surrounding tissue (39,52,53), and subsequently 
use simple, first-principle models to relate phase changes to Yv.  The technique involves first 
visualizing a penetrating vein in an MRI phase image, typically acquired with gradient echo 
imaging at a fixed echo time (TE).  Two regions of interest (ROI) are drawn: one within the 
vein, and one in the surrounding tissue. The average phase within each ROI is measured and 
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the phase difference (∆φ) between the ROIs calculated.  Combined with an additional 
estimate of the angle between the local segment of the measured vein and the direction of 
the static magnetic field (θ), ∆φ, TE, and the magnetic field strength (B0) allow an estimate of 
the magnetic susceptibility difference (∆χ) between the vein and surrounding tissue.  The 
relationship requires an assumption of the vein segment as an infinite cylinder (i.e. length >> 
diameter).  An additional equation relates the susceptibility difference ∆χ to venous blood 
oxygen saturation (Yv). 
Strengths of the phase-based approach: 
1. Acquisition is easy to perform on conventional MRI scanners, since standard MRI 
pulse sequences are used.  
2. Theoretical framework is straightforward and based on first principles of 
magnetostatics. 
3. Existing methods offer clinically feasible Imaging times. 
Weaknesses of the phase-based approach: 
1. Manual, visual identification of candidates veins is required; technique can not be 
used to quantify regional or voxel-wise Yv, OEF, or CMRO2. 
2. Static magnetic field inhomogeneity caused by non-dHb sources can bias the 
measured phase in veins or surrounding tissue.  
3. Measurements are heavily influenced by partial volume effects, which occur when 
the vessel diameter is on the order of the voxel size.  Thus, the imaging resolution 
sets a lower limit to the size of vessels that can be analyzed.  At current imaging 
resolutions on clinical scanners, the smallest targeted vessel diameter is ~1 mm.   
4. Vessel geometry must be known to a) estimate the angle between the vein and B0, 
and b) satisfy the infinite-cylinder approximation.  This latter point will also restrict 
the minimum size of the analyzed vessel (regardless of imaging resolution), since 
smaller vessels (especially in the microvasculature) have tortuous and non-linear 
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geometry.  In this way, there is an absolute limit to the spatial resolution of this 
technique that is quite low.   
Implications of vessel size limitation described in 2) and 3) are important.  Veins contain 
deoxygenated blood originating from capillaries; the larger the vein, the more numerous are 
its capillary sources.  As such, if the vein is large, measured Yv will reflect oxygen exchange in 
many capillary beds that occupy a relatively large region.  As a result, it will be impossible to 
discriminate focal OEF and CMRO2 changes in smaller regions.  In this way, the minimum 
vessel size sets a hard limit to spatial specificity of OEF and CMRO2 measurement by phase-
contrast methods.   
1.4.3.2 Extravascular T2’-based methods to estimate Yv 
A second class of methods (54) invokes an MRI signal model that quantifies Yv based on dHb-
induced signal loss in extravascular tissue; in other words, tissue surrounding blood vessels.  
This model assumes a so-called “static-dephasing regime”, a regime where the MRI signal is 
influenced only by static magnetic field inhomogeneities, and ignores effects of diffusion.  In 
the static dephasing regime, the phase distribution at a given TE is identical to local magnetic 
field distribution around vessels containing paramagnetic dHb particles.  This allows the 
derivation of a relationship between the dHb-induced frequency shift and the Yv within the 
vessels (assuming a random orientation of vessels in the voxel space).  It follows that the 
relaxivity due to these static field inhomogeneities (characterized by a R2’, which is inversely 
related to the time constant T2’; i.e. R2’=1/T2’) is the product of blood volume and this 
frequency shift.    
R2’ is the difference between R2* (1/T2*) and R2 (1/T2) and can thus be estimated by 
measuring T2 and T2*, using gradient echo and spin echo MRI sequences, respectively.  
Extravascular-based methods typically use a hybrid spin-echo and gradient multi-echo 
sequence where R2’ is estimated by removing the R2 effect from the net signal collected ( R2’ 
= R2* - R2).   
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The theoretical framework linking the MRI signal and these aforementioned parameters 
to Yv is complicated and does not have an analytical solution; asymptotic forms appropriate 
for different time scales are used for approximation (54).          
One approach by An and colleagues uses a single compartment model that assumes that 
MR signal originates from a single extravascular tissue constituent, and ignores blood and 
CSF signal.  Using this model, they produced OEF (54) and CMRO2 (55) maps based on the 
aforementioned T2’ methodology.  He and Yabolinskiy take this approach a step further by 
considering a multiple-compartment model, which factors the effects of blood and CSF on 
the MR signal (56). They dub this modified technique quantitative BOLD (qBOLD).   
Strengths of extravascular-based methods: 
1. OEF and CMRO2 maps are created on a voxel-by-voxel basis, allowing regional 
assessment of absolute OEF and CMRO2.  Such a feature is invaluable for clinical 
applications that require oxygen status in focal lesions.   
2. Hybrid spin echo and gradient multi-echo sequences offer a clinically feasible imaging 
time.  The methods by An and Lin have been used for evaluation of acute stroke and 
post-stroke recovery in patients (57).  To our knowledge it is the only absolute OEF or 
CMRO2 MRI technique implemented in a clinical study.  
3. Existing methods offer clinically feasible Imaging times. 
Weaknesses of extravascular-based methods: 
1. Static-dephasing approximations do not hold around capillaries; water diffusion 
substantially affects the MRI signal and subsequently the R2’ measurement.   
2. The assumption that voxels contain infinitely long, randomly oriented cylinders may 
be violated in parenchymal brain regions (58), thus introducing bias into the derived 
signal equation.    
3. The An and Lin method ignores intravascular and CSF components of the MRI signal.  
Despite low blood and CSF volume in parenchymal tissue, these constituents affect 
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the MRI signal and bias the estimated Yv.  qBOLD compensates for blood and CSF, but 
requires a priori knowledge of fractional tissue composition.   
4. Extravascular techniques are not amenable to fMRI for two reasons:  a) they assume 
a constant blood volume in the signal model, which does not apply during functional 
activation (59), and b) fMRI time series cannot be generated since acquisition time 
per volume is on the order of minutes (versus seconds).  Any functional paradigm 
beyond the most basic block designs will be difficult to implement under those time 
constraints.  
5. Static magnetic field inhomogeneities and susceptibility effects caused by air-tissue 
interfaces substantially bias T2’ measurements, especially at higher fields.  In other 
words, the MRI signal is not completely independent of non-dHb effects.  
1.4.3.3 Intravascular T2-based based methods to estimate Yv 
A third class of methods to measure Yv relies on an intravascular T2-based approach.  This 
approach is based on a signal model relating the T2 of blood measured within the venous 
vasculature to Yv.  It quantifies effects of dHb on the intravascular MRI signal (in contrast to 
the prior extravascular-based methodology).   This approach relies on a theoretically and 
empirically derived relationship between blood transverse  relaxation time (T2) and blood 
oxygen saturation (Y) (60).   
The major challenge for this class of methods is isolating pure blood signal from the 
appropriate venous vasculature, without contamination from extravascular constituents or 
non-venous blood.  Given that a typical voxel in gray or white matter parenchyma contains 
less than 5% blood by volume (61), this poses a significant hurdle.  As such, most methods in 
this class target blood in large veins, as it is easier to isolate pure blood signal from vessels of 
this caliber.  Until recently, candidate vessels were identified manually by visual inspection, 
or by functional activation experiments, as done by Oja et al. (62) and Golay et al. (63).  
These two studies use BOLD contrast to first locate veins draining from activated sites and 
then measure Yv within the vessel-containing voxels.  Most recently, Hu et al. proposed T2-
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Relaxation Under Spin Tagging (TRUST) MRI and measured Yv in the sagittal sinus (64).  
TRUST-MRI addresses a primary challenge of the T2-based methods by allowing complete 
isolation of blood-signal, using spin-labeling based methodology to preserve signal from 
flowing blood and eliminate signal from static tissue.  However, since TRUST isolates blood in 
only large draining veins, only global Yv estimates are possible.  
Strengths of intravascular T2-based methods: 
1. Empirical relationships between T2 and blood oxygen saturation can be established 
via in vitro calibration using vials of differentially oxygenated blood. 
2. Intravascular T2 effects are predominately based on dHb and are independent of 
macroscopic and microscopic magnetic field variations (since signal from tissue is not 
considered).    
3. Existing methods offer clinically feasible Imaging times. 
Weaknesses of T2-based intravascular techniques: 
1. Choosing voxels that contain only blood is difficult, due to partial voluming with 
extravascular constituents.  As a consequence, imaging resolution sets a lower limit 
to the size of vessels that can be analyzed.  While TRUST is free from partial voluming 
limitations, it can only target large draining veins.  As such, current implementations 
cannot quantify regional or voxel-wise Yv, OEF, or CMRO2. 
2. Empirical T2 versus Y relationships are typically valid for particular field strengths and 
certain pulse train qualities.  For maximum accuracy, in vitro calibration must be 
performed using an identical experimental setup used for in vivo acquisition.   
3. Since venous blood makes up only 5% of the typical parenchymal voxel, poor signal-
to-noise ratio will limit regional approaches.  
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1.5 Novel approach:  QUantitative Imaging of the eXtraction of Oxygen 
and TIssue Consumption (QUIXOTIC) 
In this dissertation, an innovative technique capable of quantifying absolute CMRO2 and OEF 
on a voxel-by-voxel basis is presented.   The technique uses intravascular T2-based 
methodology described in section 1.4.3.3, but overcomes its largest limitation: isolation of 
post-capillary venular (PCV) blood signal, enabling the ability to measure regional OEF and 
CMRO2.    
A novel MRI pulse sequence and excitation scheme is proposed that uses velocity-
selective spin labeling to isolate PCV blood signal.  In principle, the methodology uses 
velocity-sensitive pulses to exploit heterogeneous blood velocities and unidirectional flow in 
the vascular tree, to create a flow-dependent venular blood component that persists after 
control-tag subtraction.  This sequence incorporates T2-preparation-based technology, 
acquires PCV-blood-weighted images at multiple effective echo times, and exponentially fits 
these data to estimate post-capillary-venular blood T2.  T2,blood versus Y curves (with 
hematocrit as an independent parameter) are then generated from theoretical models and 
existing 3 Tesla data, and are used to calibrate PCV-blood T2 to Yv.  OEF is then estimated 
from Yv and combined with CBF (measured with arterial spin labeling MRI) and hematocrit to 
quantify CMRO2.  This new approach is dubbed QUantitative Imaging of eXtraction of 
Oxygen and TIssue Consumption or “QUIXOTIC”. 
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Chapter 2  
QUIXOTIC: Methods 
The generalized QUIXOTIC approach can be divided into four distinct steps: 
1. Isolation of post-capillary venular blood on an voxel-by-voxel basis, using venular-
targeted velocity selective spin labeling  
2. Measurement of T2 MRI relaxation of isolated venular blood 
3. Calibration of venular-blood T2 to venular oxygen saturation (Yv) and OEF 
4. Estimation of CMRO2 from OEF and additional CBF and hematocrit measurement  
The following sections describe these steps in detail.   
2.1 Venular-targeted velocity selective spin labeling 
The key innovation behind QUIXOTIC is venular-targeted velocity selective spin labeling (VT-
VSSL).  VT-VSSL allows targeting of MR signal exclusively from the post-capillary venular 
blood compartment, from which T2, and subsequently Yv, can be measured.  In principle, the 
methodology uses velocity-sensitive MR pulses to exploit heterogeneous blood velocities 
and unidirectional flow in the vascular tree (i.e. from arteries to capillaries to veins) to create 
a flow-dependent venular blood component.  The two-step data acquisition paradigm 
creates control and tag images with and without the desired venular-blood component, 
respectively. Subsequent pairwise control-tag subtraction eliminates signal from static 
tissue, CSF, and non-venular blood compartments, leaving an image exclusively containing 
blood in the post-capillary venules.   
 QUIXOTIC is adapted from velocity-selective arterial spin labeling (65), and employs 
similar velocity selective (VS) modules to saturate signal from blood spins flowing above a 
given cutoff velocity.  Also like VS-ASL, QUIXOTIC creates flow-derived MR signal from within 
the imaging voxel itself, which is fundamentally different from prior spatial-based spin 
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labeling techniques.  The pulse sequence is summarized schematically in Figure 2-1 and is 
played once for the tag acquisition and once for the control acquisition.  Details of the VS 
module are presented in section 2.1.3.   
 
Figure 2-1.  QUIXOTIC pulse sequence. 
Incorporated into VS2 is a T2-preparation module (described in 2.2.1) (66), which allows 
T2 estimation via data acquisition at multiple echo times.  An important feature of the 
sequence is an inversion pulse at TO1, which compensates for adverse effects of T1 relaxation 
that could potentially introduce unwanted signal from non-venular blood. 
The difference between the tag and control acquisitions lies within the second velocity 
selective module.  The tag acquisition employs a user-defined cutoff velocity (VCUTOFF) for 
both VS Module I (VS1) and VS Module II (VS2), while the control uses VCUTOFF for VS1, but 
disables velocity selection for VS2 (i.e. moving spins are unaffected, VCUTOFF = infinity).  
2.1.1 Properties of QUIXOTIC pulse sequence  
2.1.1.1 Neglecting T1 relaxation and TO1 inversion pulse 
To introduce properties of this sequence, T1 relaxation and the inversion pulse at TO1 are 
neglected. Figure 2-2 provides an idealized cartoon depicting blood spins in the circulation 
for both control and tag acquisitions, their history through the pulse sequence timing, and 
the final spin contribution in the subtracted image.   At t=0, before VS1, all blood spins 
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(arterial, venous, capillary) are relaxed (Figure 2-2a). Strong velocity weighting (low VCUTOFF) 
is then applied during VS1 for both tag and control, which selects for slow moving spins in 
small arterioles, capillaries, and small venules (V < VCUTOFF), and saturates (i.e. eliminates) 
faster moving spins in larger vessels (V > VCUTOFF) (Figure 2-2b).  Notably, this large-vessel 
signal is eliminated on both sides of the circulation.  After VS1, the outflow time (TO) allows 
the targeted blood to flow out of the small vessel compartments and accelerate into larger 
venular vasculature (Figure 2-2c). VS2 is then applied at TO. This time, however, the tag and 
control acquisition experience different velocity weighting; the tag sees velocity selection at 
VCUTOFF, but the control experiences no velocity weighting. Spins that have accelerated above 
VCUTOFF during TO are saturated in the tag acquisition, but left unaltered in the control (Figure 
2-2d). As imaging starts immediately after VS2, subtraction of tag from control yields an 
image weighted to blood that has accelerated from below VCUTOFF, to above VCUTOFF, during 
TO (Figure 2-2e). Assuming unidirectional flow (arterial to capillary to venous), these spins 
will reside only in the venous compartment. Other spins (static, CSF, non-venular blood) are 
eliminated via the subtraction. If VCUTOFF and TO are chosen properly, signal from PCV blood 
is exclusively targeted.   
 
Figure 2-2.  QUIXOTIC spin history diagram, neglecting both T1 relaxation and inversion pulse at TO1. 
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2.1.1.2 Including T1 relaxation but neglecting TO1 inversion pulse  
T1 relaxation complicates this idealized model. Spins saturated by VS1 at t = 0 experience T1-
longitudinal magnetization recovery, as indicated by the blue arrows in Figure 2-3c.  When 
velocity selection via VS2 occurs, spins in the control module are unaffected, and spins 
above VCUTOFF are saturated. This leads to a mismatch in spin magnitude in the non-venular 
compartments of the control and tag; at TO, spins from these unwanted compartments are 
partially recovered in the control, but fully saturated in the tag image (Figure 2-3d). Without 
modification, these unwanted spins will not subtract completely, and QUIXOTIC loses venous 
selectivity. In addition to the desired, fully relaxed spins (black arrows), a non-insignificant 
quantity of spins from arterial and late venous compartments (blue spins in Figure 2-3e) 
contribute to the final image.   
 
Figure 2-3.  QUIXOTIC spin history diagram, considering T1 relaxation, but excluding inversion pulse at TO1 
2.1.1.3 Including T1 relaxation and TO1 inversion pulse  
To compensate for this T1-based phenomenon, a non-selective inversion pulse is placed at 
time TO1 such that spins initially saturated by VS1, will exactly re-grow to the null point by 
TO.  Spins in unwanted populations thus end up saturated in both control and tag images, 
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leaving only desired PCV blood upon subtraction.  TO1 is computed using basic MR relaxation 
equations to determine the required interval to produce a null of blood magnetization re-
growing from saturation. T1,blood is assumed as 1660 ms (67).  Figure 2-4 diagrams the 
complete spin history during the final QUIXOTIC experiment and depicts the effects of the 
inversion pulse played at a TO1.   
In this more realistic depiction, spins saturated by VS1 recover with T1 as they flow 
through the circulation (Figure 2-4c, blue arrows).  At time TO1, the inversion pulse rotates 
all spins by 180 degrees (Figure 2-4d).  During the following interval (before TO), these 
inverted spins recover with T1; the ideal TO1 choice will result in initially saturated spins 
exactly reaching the null point at TO (Figure 2-4e, black circles). Initially relaxed spins will 
have decreased in magnitude, but will still contribute to the MRI signal (Figure 2-4e, red 
arrows).  At TO, VS2 saturates spins above VCUTOFF in the tag image only (Figure 2-4f); 
however, because the undesired spins in the control image are nulled, neither pool will 
contribute to the final signal.  Consequently, the desired venular component remains in the 
final subtraction (Figure 2-4g).   
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While the addition of the TO1 inversion pulse is crucial for VT-VSSL to remain specific to 
the venular compartment, spins not saturated by VS1 also experience magnetization 
inversion, and subsequently T1 relaxation. Consequently, the final venular signal component 
in the subtraction image will be reduced compared to the original equilibrium 
magnetization.  The degree of this attenuation will increase with TO.      
2.1.2 VCUTOFF and TO parameters 
Velocity Cutoff (VCUTOFF) and Outflow Time (TO) are the two key parameters in QUIXOTIC. 
These parameters define the nature of the QUIXOTIC signal and directly control its spatial 
specificity, signal intensity (SI), and maximum SI. When taken together, VCUTOFF and TO 
determine the extent of the velocity-selected bolus at imaging time, by defining its trailing 
and leading edge, respectively. The venular-blood component that remains in the subtracted 
image is accordingly determined.   
2.1.2.1 Outflow time (TO) 
The outflow time TO of the QUIXOTIC experiment determines the SI and spatial specificity of 
the subtracted venular-blood component.  During TO, blood spins accelerate above the 
VCUTOFF threshold and into receiving venular vasculature within the imaging voxel.  Imaging 
signal is created, and intensity increases as these spins begin to fill the imaging voxel.  The 
final signal intensity is directly proportional to the volume of spins that have accelerated 
above VCUTOFF during TO, while still remaining within the voxel (hereafter termed as “imaging 
spins”).   
As imaging spins disseminate through the tortuous venular microvasculature during TO, 
they flow deeper into the venous circulation, and the leading edge of the bolus travels 
further away from capillary sites of gas exchange.  As long as these spins do not leave the 
voxel, oxygen saturation within these pools properly represents oxygen exchange of their 
capillary sources.  Spatial specificity is perfectly preserved, and imaging spin volume is 
exactly the product of venular outflow and TO. 
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As TO increases, however, imaging spins eventually leave their voxel of origin, and do so 
one in one of two ways:  1) clear through to the larger venous circulation outside of the 
imaging slice, or 2) clear through to larger venous vasculature in adjacent voxels but stay 
within the imaging slice.   These cleared spins do not contribute signal to the source voxel, 
and thus do not represent oxygenation within this voxel; in this respect, they can be 
considered lost signal.  In the former case, cleared spins do not affect spatial specificity, 
since they have left the imaging slice entirely.  Spins in the latter case, however, will 
contribute to signal intensity of neighboring voxels and compromise spatial specificity.  
Based on these phenomena, the lower the TO, the higher the spatial specificity. 
However, because SI (and therefore SNR) increases with TO, there is a trade-off 
between spatial specificity and SNR.  Both must be considered for optimal QUIXOTIC 
performance, and TO should be selected based on the SNR and spatial specificity 
requirements of the intended application.  In this way, it is possible to choose TO such that 
imaging spins will maximally occupy venules in the imaging voxel, with only a relatively small 
proportion having departed.  This optimal TO will lead to high SI, with only a marginal loss of 
spatial specificity.   Of note, blood T1-relaxation should also be considered when choosing 
TO, since longer TOs will result in substantial loss of signal due to T1 recovery.  
2.1.2.2 Velocity cutoff (VCUTOFF)  
VCUTOFF determines the maximum possible SNR of the venular-blood component in the final 
image, by defining the maximum available vascular volume that can be occupied by the 
venular bolus.    Since blood velocity is closely related to vessel caliber, VCUTOFF not only 
defines the cutoff blood velocity, but also determines how far into the venous vascular tree 
the trailing edge of imaged bolus originates.  A low VCUTOFF means that imaging spins 
originate closer to the distal end of the capillary bed, while a high VCUTOFF means that imaging 
spins originate closer to terminal draining veins.  As VCUTOFF increases, imaging spins originate 
from points farther along the venous vascular tree, effectively reducing the remaining 
vascular voxel volume that can be filled by outflowing imaging spins.  In this way, VCUTOFF sets 
a hard limit to the maximum volume of imaging spins that can occupy a voxel, with lower 
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VCUTOFFs offering higher SI at the optimal TO.  A VCUTOFF just above capillary blood velocities is 
the ideal choice.  A VCUTOFF lower than capillary velocities is undesirable for three reasons: 1) 
VS theory assumes laminar flow, not capillary plug flow, for proper velocity filtering (65), 2) 
as VCUTOFF decreases, the relaxed blood pool available to flow above VCUTOFF will at some 
point become too small, also resulting in SNR reduction, and 3) when large velocity-
weighting is applied, tissue or CSF water diffusion becomes a contaminating source of signal 
(65). 
Another way to model signal generation in QUIXOTIC is to visualize imaging spins 
emerging from many different spatial sources within the voxel.  The number and location of 
these sources is based on the spatial distribution of the voxel microvasculature and the 
VCUTOFF parameter choice.  At the theoretically ideal VCUTOFF (i.e. right above capillary blood 
velocities), there will be many sources scattered throughout the typical MRI gray-matter 
brain voxel, simply due to the high capillary density.  Imaging spins flow from these sources 
during TO, and at the optimal TO, will fill a large fraction of the voxel venular vasculature.  As 
VCUTOFF increases, however, these points move further down the vascular tree and merge.  
This results in a reduction of source density and distal available vascular volume, both of 
which result in an SNR decrease.  At the extreme, VCUTOFF increases so much such that venous 
vessels within the voxel do not contain blood flowing below VCUTOFF.  The number of sources 
drops to zero, no imaging spins emerge, and image the subtraction is void of signal.    
2.1.3 The velocity selective (VS) module  
The principal component of the QUIXOTIC excitation scheme is the velocity selective 
module. A unique property of MRI is the ability to phase encode position and its time 
derivatives by applying magnetic field gradients; this property enables velocity selective MRI 
(68). The simplest means of phase-encoding involves implementation of a bipolar gradient 
pulses, or equivalently unipolar pulses separated by a 180° refocusing pulse.   Inserting this 
phase-encoding scheme between two excitation pulses with opposite phase ( 90 90°− ° ) 
results in the following RF pulse train: 90 G 180 G 90°− − °− − °
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flow systems found in non-capillary vasculature of the human circulatory system, the result 
is an approximate preservation of blood spin magnetization flowing below a certain velocity 
cutoff (VCUTOFF) and elimination of magnetization from spins flowing above VCUTOFF.  In reality, 
however, the velocity filter produces a sinc-like modulation:   
 ( )z 0M M sinc 2 vβ= ⋅  [5] 
where M0 is the initial magnetization, v is spin velocity. β is related to the separation (∆), 
duration (δ), and amplitude (G) of the bipolar gradient pulses in the following manner: 
 
G
2
γ δ∆β =  [6] 
where γ is the gyromagnetic ratio for protons.  The first zero-crossing thus defines VCUTOFF 
(65,69): 
 cV 2 G
pi pi
β γ δ∆= =  [7] 
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Figure 2-5 displays the sinc-filter profile and the ideal velocity filter for comparison.     
 
Figure 2-5.  Modulation produced by velocity selective pulse; ideal case (black rect function), and real case 
(blue sinc function).  The red shaded area represents spins from below the designated VCUTOFF that will be 
included in the final venular bolus.   
Compared to the ideal velocity profile, which provides a binary response with respect to 
signal preservation or elimination, the real velocity filter offers a more graded response.  As 
a consequence, spins flowing below the nominal VCUTOFF (represented by the shaded area in 
Figure 2-5) will contribute fractional signal to the final venular bolus, thus moving the trailing 
edge of the bolus towards the distal end of the capillary beds.  In this way, based on 
arguments presented in section 2.1.2.2, maximum SNR is increased compared to that 
afforded by an ideal rect filter profile.       
2.1.3.1 Construction of the velocity selective (VS) module 
Instead of using a 90 G 180 G 90°− − °− − ° pulse train, which can be implemented with simple 
hard RF pulses, a four RF and four gradient approach was used, as suggested in (65): 
 ( )90 G 180 G G 180 G 90+ − + −°− − °− − − °− − °  [8] 
and incorporates adiabatic pulses as the refocusing 180°s.  If properly tuned, this train offers 
greater resistance to transmitted field (B1
+) and static field (B0) inhomogeniety, water 
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diffusion, and eddy current effects (65,70).  Prior investigations employing this eight-pulse 
sequence (65) verify its superior performance with reduced artifacts compared to data 
acquired with the simpler 90 G 180 G 90°− − °− − °  train (69).  The final VS train used for VT-
VSSL adds a gap (δE) between gradient lobe four and the flip-up 90° RF pulse to reduce 
artifacts caused by the gradient’s fastest eddy current components. To maintain the 
symmetry of the pulse train, the same gap is added between the flip-down 90° pulse and the 
first gradient lobe.  The final VS train is shown in Figure 2-6; for perfect spin-echo refocusing, 
the adiabatic refocusing pulses are symmetrically spaced.  
 
Figure 2-6.  RF and gradient waveforms for velocity selective module. 
Before deployment of the VS module, the two adiabatic refocusing 180° pulses require 
optimization.  Unlike conventional RF pulses, which are amplitude-modulated, adiabatic 
pulses are frequency modulated and have unique properties.  One important property is 
that once RF transmission power reaches a critical threshold, the applied flip angle remains 
constant and is insensitive to B1
+ variations. In addition to B1
+ insensitivity, adiabatic RF 
pulses can also be designed for maximal efficiency across a large range of frequencies, and 
are therefore resistant to variations in the main static magnetic field (B0) as well.  As such, 
adiabatic pulses have been especially useful as inversion pulses for arterial spin labeling (71) 
and spin-echo refocusing pulses for T2-weighting (66).     
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Traditionally, most adiabatic refocusing pulses are very long, often ranging from 20 to 
30 milliseconds.  This duration is necessary to achieve the desired flip angle without running 
into specific absorption rate (SAR) issues2.  However, since T2 relaxation occurs during the VS 
module, such a lengthy pulse will result in large values of τ (i.e. spacing between sech 
pulses), and thus substantial signal loss.  RF pulses, however, can be transformed into 
shorter pulses using VariablE Rate Selective Excitation (VERSE) theory (72), which 
dramatically reduces pulse length without a major increase in power or SAR.  VERSE theory is 
thus employed to transform a 32 ms adiabatic pulse into a pi millisecond VERSEd adiabatic 
pulse (Figure 2-7).  The specific type of adiabatic pulse used is based on a hyperbolic secant 
(sech) design.  
 
Figure 2-7.  Example magnitude (top-left) and phase (lower-left) of traditional adiabatic sech pulse (black) 
and corresponding VERSEd adiabatic sech pulse (green).  The VERSE process decreases the length of the pulse 
by an order of magnitude, with an increase in power much less had the pulse been shortened by traditional 
means (i.e. time compression).  The VERSEd pulse can also be view in its real (top-right) and imaginary 
(bottom-right) forms.   
                                                      
 
2 SAR is the rate at which energy is absorbed by the body during pulse transmission and must be sufficiently 
low to prevent body temperature increases and other dangerous situations.    
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Final optimization of these VERSEd sech pulses involved inserting them into the VS 
module and then searching the sech-specific µ and β parameter space.  Specifically, this 
entailed maximizing the final longitudinal magnetization (Mz) at the end of the VS module 
and minimizing the final transverse magnetization (Mxy), with µ and β as free parameters.  
The optimization process was subject to these design constraints:   
1. Frequency selectivity to include blood.  Since QUIXOTIC relies on spin manipulation of 
blood water protons, it is essential that the VS train properly manipulates blood 
water spins at all physiological oxygenation levels.  It was thus decided to optimize 
for a frequency range of ±100 Hz, which at 3 Tesla should account for the maximum 
possible blood frequency shift (11,73).   
2. B1 insensitivity from 85% maximum RF transmit power to maximum RF transmit 
power.  Prior data from human studies on a Siemens 3T Tim Trio System (Siemens 
Medical Solutions, Erlangen, Germany) have indicated measurable B1
+ inhomogeneity 
across the human brain, with anterior regions receiving approximately 15% less than 
requested transmit power (data not shown).  Thus, it was necessary to optimize the 
VS train across this entire range (i.e. from 0.85 maximum transmit power to 
maximum transmit power) to ensure the adiabatic threshold was reached across the 
entire brain.  Additionally, by optimizing across the entire range (as opposed to 
simply searching for the threshold voltage), any deviations from ideal adiabatic 
performance are accounted for – in reality, the flip angle is not absolutely flat beyond 
the adiabatic threshold, but can experience a slight wobble depending on B1
+, even 
under simulation.   
The optimization was performed by using a custom Bloch equation simulator (Brain 
Hargreaves, http://mrsrl.stanford.edu/~brian/mritools.html, Stanford, CA) in MATLAB 
(Mathworks, Natick, MA).  µ and β were found to be 4 and 400 s-1, respectively.  This 
parameter optimization space is graphically depicted in Figure 2-8.   
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Figure 2-8.  Mu and Beta optimization process.  Mu = 4, Beta = 400 rad/s maximizes magnetization left in Mz 
and minimizes magnetization left in Mxy after VS module playback.   
2.1.3.2 Diffusion Weighting 
The 90 G 180 G G 180 G 90+ − + −°− − °− − − °− − °  train used to encode velocity has an 
unintended effect in this application:  diffusion weighting.  Diffusion weighting suppresses 
signal based on the diffusion coefficient (D, mm2/s) and so-called “b” factor (s/mm2).  D 
typically depends on the structure of water-containing tissue and is highest in brain 
compartments where diffusion is least restricted (e.g., cerebrospinal fluid, CSF).  Like the 
VCUTOFF parameter, the b-value is related to the separation (∆), duration (δ), and amplitude 
(G) of the bipolar gradient pulses, but in a slightly different manner: 
 ( )2b Gγ δ ∆=  [9] 
Consequently, analogous to the velocity weighted scenario, the control and tag images in 
VT-VSSL will have differential amounts of diffusion weighting in the control and tag images 
(due to differences between the control and tag VS2 module).  If the difference is large 
enough, contrast from water diffusion will appear in the final subtracted images, and 
venular-blood selectivity will be compromised.  One strategy to minimize these diffusion 
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effects in the VT-VSSL experiment is to achieve the desired VCUTOFF by increasing ∆ instead of 
G or δ.  Since VCUTOFF is linearly related to all three parameters and b is quadratically related 
to G and δ and linearly related to ∆, increasing ∆ is the optimal way to decrease VCUTOFF 
without drastically increasing b.  Luckily, because the values of G, ∆, and δ required for 
effective VT-VSSL are much smaller than those typically used in diffusion weighting 
applications, the contribution of diffusion weighting in QUIXOTIC is quite small.   For VCUTOFFs 
used in this work, the gradient parameters yield b у 1 mm/s.  This value was deemed 
acceptable in prior VS-ASL experiments, based on minimal diffusion contribution in the 
subtraction images.  The impact of diffusion-weighting on QUIXOTIC accuracy is explored 
further in Chapter 3.   
2.1.4 Initial testing of VS-ASL/ VT-VSSL sequence with VS module 
2.1.4.1 Phantom testing 
The first round of experiments incorporated the VS module shown in Figure 2-6 into the 
pulse sequence depicted in Figure 2-1.  Imaging was first performed in water phantoms to 
test fidelity of control-tag subtractions, which were deemed acceptable for both VS-ASL and 
VT-VSSL approaches.  Phantom testing beyond this was unnecessary, since available 
phantoms did not contain moving spins.  
2.1.4.2 Human testing: VS-ASL 
For initial tests of the VS module in humans, a previously known VS-ASL technique with 
example images was implemented (65,69).  If the VS module is not effective in this known 
VS-ASL application, it would be suboptimal for VT-VSSL application.  Initial VS-ASL 
acquisitions were performed using parameter values and data processing schemes similar to 
those described in the literature (65,74).  As suggested by the image in Figure 2-9a (and 
others not shown), initial attempts at VS-ASL yielded images of comparable or better quality 
than those already published.  The custom VS module was thus deemed effective in a VS-ASL 
application.  
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VS-ASL Scan Parameters:  matrix size = 64x64, voxel size 3.9x3.9x10 mm3, PPF = 6/8, TI = 
1000 ms, VCUTOFF = 2.4 cm/s (G = 1.64, ∆ = 17.8 ms, δ = 1 ms, x-directed velocity weighting), 
EPI readout, TE = 13 ms, TR = 3 s, 120 measurements, scan time = 6 min).   
2.1.4.3 Human testing: VT-VSSL  
Based on excellent VS-ASL results, preliminary VT-VSSL experiments that implemented 
various combinations of VCUTOFF and TO were attempted.  The attempts resulted in a signal 
intensity bias from the left side to the right side of the brain in the venular-blood image.  
This artifact was mitigated by inserting a 350 microsecond gap (δE = 350 µs) between the 
fourth gradient lobe and the 90° flip-up pulse (mentioned in 2.1.3.1).  This gap presumably 
reduced short time-constant eddy current effects.   
A VT-VSSL parameter combination of VCUTOFF = 2.0 cm/s (G = 1.6, ∆ = 17.0 ms, δ = 2 ms) 
and TO = 725 ms (resulting in TO1 = 400 ms) was empirically found to generate venular-blood 
images with adequate SNR and signal well-confined to cortical gray matter areas (i.e. areas 
of high blood flow); an example is provided in Figure 2-9b.  The remaining imaging 
parameters were identical to the VS-ASL scan, save for the following: TR = 4s, 80 
measurements, scan time = 5m 30s.  A TR of 4 s yielded the highest SNR in venular-blood 
images, likely due to additional inter-measurement T1 relaxation providing near-fully relaxed 
blood for the venular bolus in the next measurement.  
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Figure 2-9.  VS-ASL (a) and VT-VSSL (b) images for validation of optimized VS module and pulse sequence. 
2.1.4.4 Velocity encoding direction 
While velocity encoding gradients can be applied in any of the three spatial dimensions, 
preliminary investigations were successful with only x-directed gradients.  Mean subtraction 
images acquired with gradients along y and z dimensions were more artifact-prone and 
exhibited significantly higher intensity variance within voxels across the subtracted time 
series (as told by temporal standard deviation maps). Future implementations will 
investigate these directional biases and attempt to encode velocity in all three spatial 
dimensions, enabling up to a 3x increase in SNR.  
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2.2 Measurement of venular-blood T2  
2.2.1  Incorporation of T2-preparation into VS2 for multi-echo imaging 
As an intravascular T2-based technique, QUIXOTIC first acquires venular-blood-weighted 
images at multiple echo times (TEs), and then determines T2 by exponentially fitting image 
signal intensity versus TE.   Venular-weighted image acquisition was successfully 
accomplished in section 2.1; extending these methods to multiple-echo acquisition is done 
by elongating the VS module, while keeping its spin-echo properties.  
The RF pulse train of the VS module resembles a so-called “T2-preparation” sequence, 
since T2 decay is the prominent relaxation process within the module.  The 90 flip-down 
pulse first rotates the longitudinal magnetization into the transverse plane.  The gradient 
pulses then serve to saturate spins flowing above VCUTOFF.  The spins flowing below VCUTOFF, 
however, are preserved, but still experience T2 transverse relaxation.  As long as the 
refocusing 180° pulses are in proper spin-echo position (as in Figure 2-6), these spins will 
experience T2 decay. The flip up 90° returns the magnetization to the Mz plane, effectively 
stopping the T2 decay process.     
One way to extend the T2 decay process is to elongate the VS module by adding pairs of 
the adiabatic sech 180° pulses (such that the sech spacing remains fixed) between the flip-
down 90° pulse and first VS gradient lobe.  For each pair of sech pulses added echo time (TE) 
is incremented by 2·τ, which equivalently sets the ∆TE.  In this manner, experiments at 
various echo times can be performed. 
Of the two candidate VS modules for the multi-TE, T2-preparation scheme, VS2 was 
chosen since it immediately precedes the data acquisition module.  Acquired images will be 
T2-weighted without contamination from any T1 relaxation occurring between the hybrid 
VS2/T2-prep module and image acquisition. 
Figure 2-10 presents an example of a hybrid VS2/T2-preparation module for the third TE 
acquisition (TE3).  Adding additional sech pairs will further increment the echo time, allowing 
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venular-blood images at many TEs.   The minimum ∆TE is limited by ∆, δ, δE and the sech 
duration; in these experiments ∆TE was 20 ms.  
 
Figure 2-10.  VS2/ T2-preparation module with pairs of adiabatic refocusing pulses inserted between the flip-
down 90° and the velocity encoding gradients.  In the above sample module, three pairs refocusing pulses 
indicate the third TE acquisition (i.e. TE3), as marked by three ∆TE intervals.     
As TE is incremented by elongating the VS2/T2-preparation module, the overall timing of 
the pulse sequence will shift.  An unintended consequence is that the imaging module will 
start at a different point within the sequence timing for each successive TE.   Since signal 
intensity is determined by the volume of imaging spin outflow, the differential imaging times 
will result in differential signal intensity not solely due to T2.  Flow sensitivity is introduced 
into the technique, and observed T2 will not reflect the true T2 of venular blood.   To 
maintain flow insensitivity, the EPI module must remain at the same point within the timing 
diagram, regardless of TE.  To meet this requirement, the VS2/T2-prep module is extended 
into the pulse sequence as TE is incremented; that is, the onset time of the module 
decreases by ∆TE as the module lengthens by ∆TE.  Of note, shifting the start time of VS2/T2-
prep will require TO1 to be recalculated to ensure proper nulling for venular blood 
selectivity.  Together, these simple remedies will ensure that images at successive TEs differ 
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only by T2-weighting of venular-blood, not by the volume of imaging spins delivered during 
TO.   
2.2.2 Calibration of T2-preparation module 
Two additional sources of bias must be considered when employing the VS2/T2-prep module 
for multi-TE imaging.  First off, during the sech pulses, the magnetization vector traces a 
complicated trajectory through space and does not decay with free precession transverse 
relaxation (T2), but rather with so-called “rotating frame relaxation” (75).  Consequently, 
observed relaxation during the T2-preparation train is a mixture of T2 and rotating frame 
relaxation (76).  In most turbo spin echo pulse trains, as long as the duration of the RF 
refocusing pulse is short compared to the duration of the entire train, rotating frame 
relaxation can be ignored, and T2 у T2,observed.  In this application, however, the sech pulses 
make up a substantial segment of the entire train (roughly 30%), and such an approximation 
will introduce error.  Second, in a real VT-VSSL implementation the imaging readout cannot 
be placed immediately after the VS2/T2-prep module, as there is a necessary fat saturation 
module between the two. T1 relaxation will occur during this 10-15 ms interval, further 
biasing observed T2 away from the true T2.   
To compensate for these non-T2 decay mechanisms, a small adjustment was made to 
the nominal echo spacing (i.e. ∆TE) to derive an effective echo spacing (∆TEeff) that could 
then be used to more accurately estimate T2 from the measured data.  To determine the 
modification factor, the entire pulse sequence was simulated using the Bloch equation, 
assuming T1 and T2 decay during the adiabatic refocusing pulses.  The T1 and T2 used for the 
simulation were 1660 ms and 70 ms, respectively, which are approximate T1 and T2 values 
for deoxygenated blood at 3T (64,67).  A ∆TEeff appropriate for the pulse sequence was 
subsequently estimated and is expected to minimize bias in the T2 estimate of venular blood. 
The final VT-VSSL pulse sequence with integrated T2-preparation was tested on a 
custom 3% agar/ 0.03 mM gadolinium phantom with relaxation parameters similar to 
deoxygenated venous blood (T1 = 1690 ms and T2 = 58.6 ms previously measured with 
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inversion recovery and single echo spin echo sequences, respectively).  VT-VSSL with T2-
preparation was performed (5 TEeffs, ∆TEeff = 18.4 ms).  Since the phantom contained only 
static spins, only control images were acquired and the subtraction step omitted.  Average SI 
within the phantom was plotted versus TEeff; subsequent fitting yielded T2 = 55.2 ms, 
suggesting high fidelity of the T2-preparation design.  The 3.4 ms discrepancy could arise for 
several reasons. For one, despite blood-matched T1 and T2 parameters, rotating frame 
relaxation parameters of the phantom are unknown and may differ from those of venous 
blood. Additionally, in the in vivo experiment, flowing blood will experience a slightly 
different sequence of pulses and relaxation than static spins; for example, blood flowing into 
the slice-of-interest may be more relaxed, compared to in-plane static spins that will 
assuredly experience the readout excitation pulse each measurement.  Based on these 
limitations, we deemed the discrepancy minor. More accurate validation (and calibration) 
will require a perfusion phantom that more closely mimics the behavior of blood in the 
circulatory system.  
2.2.3 Imaging venular-blood at multiple echo times 
With T2-preparation technology successfully integrated into the VT-VSSL pulse sequence, 
venular-blood images were generated at multiple effective echo times.  Typical scan 
parameters are: matrix size = 64x64, voxel size 3.9x3.9x10 mm3, PPF = 6/8, TI = 1000 ms, 
VCUTOFF = 2.0 cm/s (G = 1.6, D = 17.0 ms, d = 2 ms, δE = 350 µs, x-directed velocity weighting), 
EPI readout, TE = 13 ms, TR = 4 s, 80 measurements per TEeff, six TEeff, scan time per TEeff = 5m 
30s, total scan time = 32m 30 s.   Similar to VS-ASL and VT-VSSL analyses described in 
sections 2.1.4.2 and 2.1.4.3: the raw control-tag image series from a TEeff acquisition is first 
motion corrected, then subtracted in pairwise fashion, and finally averaged to create the 
mean venular blood map.  The process is repeated for data at each acquired TEeff.  Figure 
2-11 provides sample control, tag, and mean venular-blood images from a human subject at 
six successive TEeffs.  Figure 2-12 shows the orientation of the VT-VSSL slice, overlaid on a 
sagittal structural image.  
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Figure 2-11.  Control, tag, and mean venular-blood images at successive TEeffs 
 
Figure 2-12.  Anatomical image displaying typical orientation of VT-VSSL imaging slice. 
Measurement of T2 from these images involves plotting venular-blood signal intensity versus 
TEeff and fitting with a single exponential.  In principle, the fit can be done on a voxel-by-
voxel basis to produce a T2 map.  Such an approach on these data, however, yields 
unacceptably high variances and poor goodness-of-fit measures, primarily due to inadequate 
SNR.  Alternatively, average SI within a region can be measuredand fit for T2.  Within-image 
averaging will substantially boost SNR per TEeff point, resulting in tighter fits and 
correspondingly smaller error.  For proof-of-principle, the SI from the entire cortical gray 
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matter region was averaged, plotted versus TEeff, and fit for T2.  To define voxels containing 
cortical GM, a cortical-GM-only mask is acquired at the VT-VSSL scan plance, using a double 
inversion recovery pulse sequence tuned to null WM and CSF (TI1 = 3700 ms, TI2 = 4280).   
The mask is displayed in Figure 2-13.  This mask was overlaid onto the VT-VSSL images to 
identify gray matter voxels within the VT-VSSL image.  Signal intensity from these GM 
designated voxels is averaged, plotted versus TEeff, and exponentially fit, as seen in Figure 
2-14.  In this way, cortical GM T2 is measured.  
 
Figure 2-13.  Cortical gray matter mask acquired with double inversion recovery sequence 
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Figure 2-14.  Venular-blood SI versus TEeff and associated T2 fit. 
2.3 Calibration of T2,blood to Yv and OEF  
The relationship between T2 transverse relaxation time of blood and blood oxygen 
saturation (Y) was first examined in the early 1980s (11).  In years following, a parametric 
model based on the Luz-Meiboom model of spin relaxation during two-compartment 
exchange (in this case, between plasma and the red blood cell) was derived to fit 
experimental data measuring T2,blood
 versus blood oxygen saturation (12).  Such work 
enabled MRI-based measurements of oxygen saturation in vivo.  In 1998, Van Zijl et al. 
proposed fundamental theory for T2-based signal changes in perfused tissue and presented a 
quantitative model linking T2 relaxation of blood to physiologic parameters including Y 
(60,63).  This expression can be written in terms of T2, blood, Y, and Hct in the following form: 
 ( )( ) ( ) ( )( )2
2,blood
1 A Hct B C 1 Y 1 Hct D E 1 Y
T
ª º
= + ⋅ + − + − + −¬ ¼  [10] 
where A, B, C, D, and E represent lumped biophysical parameters related to susceptibility 
differences between the red blood cell and plasma, water relaxation rates in the red blood 
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cell and plasma, and the spacing between 180° radiofrequency pulses in a CPMG spin-echo 
module (τCPMG) (60,63). 
Fit of available Y versus T2,blood data at 3T obtained from in vitro bovine blood (3T, CPMG 
multi-echo T2 sequence, τCPMG = 10 ms, courtesy of P. van Zijl and C. Clingman, Johns Hopkins 
University), yielded values the for A, B, C, D, E used in this work.   
The final independent parameter needed to utilize equation is hematocrit.  Hematocrit 
represents the fraction of blood comprised of hemoglobin-carrying red blood cells.  This was 
provided by rapid analysis of a single drop of blood (obtained by finger prick) via the Ultracrit 
device (Separation Technologies, Altamonte Springs, Florida).   Since VT-VSSL targets blood 
in primarily small venules in the microvasculature, the Ultracrit-measured hematocrit is 
multiplied by 0.85 to correct for hematocrit differences between small and large vessels 
(77).    
Finally, with all components necessary for equation [10] acquired, venular blood T2 is 
calibrated to Yv.   Ya is either assumed or measured with a pulse oximeter (8600FO Pulse 
Oximeter, Magmedix, Fitchburg, MA).  Equation [2] is then used to calculate OEF.   
A sample curve generated using microvascular hematocrit = 0.32 is displayed in Figure 
2-15, depicting an example T2-Y calibration.  
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Figure 2-15.  T2 versus blood oxygen saturation curve 
2.4 Estimation of CMRO2 from OEF, CBF, and hematocrit 
The final missing parameter necessary for CMRO2 measurement is CBF.  Arterial spin labeling 
(ASL) offers a widely-accepted approach to quantify absolute CBF on a voxel-by-voxel basis.  
Several variants of ASL are available; a pulsed ASL (pASL) scheme called PICORE/ Q2tips (78) 
offers the possibility of high-SNR perfusion-weighted maps from the identical VT-VSSL scan 
plane (Figure 2-12).  ASL-specific parameters are TI1 = 700 ms, TI1 stop time = 1400 ms, TI2 = 
1600 ms, pASL gap = 10 mm, Tag thickness = 160 mm, TR = 2000 ms, 60 measurements, 
acquisition time = 2 min.  The remaining parameters are identical to those of the VT-VSSL 
and DIR scans.  An additional M0 calibration scan is necessary to calibrate the perfusion-
weighted map to an absolute CBF map; this scan simply disables the ASL-specific pulses and 
acquires a single measurement. 
The pASL data are analyzed as described in 2.1.4.2 to generate CBF-weighted images; 
this analysis stream includes motion correction, pairwise subtraction, and signal averaging.  
These images are calibrated to absolute CBF maps by using the local tissue proton density 
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provided by the M0 scan (79).  A sample CBF map acquired with pASL is shown in Figure 
2-16.   
 
Figure 2-16.  Representative pASL-CBF map 
With this additional CBF measurement, OEF, microvascular hematocrit, and Ya, equations [3] 
and [4]  can be used to estimate CMRO2.    
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Chapter 3  
QUantitative Imaging of eXtraction of Oxygen and 
TIssue Consumption using velocity-selective spin 
labeling 
3.1 Abstract  
While oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2) are 
fundamental parameters of brain health and function, a robust MRI-based mapping of OEF 
and CMRO2 amenable to functional MRI has not been established.  To address this issue, a 
novel method called QUantitative Imaging of eXtraction of Oxygen and TIssue Consumption, 
or QUIXOTIC, is introduced.  The key innovation in QUIXOTIC is the use of velocity-selective 
spin labeling to isolate MR signal exclusively from post-capillary venular blood on a voxel-by-
voxel basis.  Measuring the T2 of this venular-targeted blood allows calibration to venular 
oxygen saturation (Yv) via theoretical and experimental T2 versus blood-oxygen-saturation 
relationships.  Yv is converted to OEF, and baseline CMRO2 is subsequently estimated from 
OEF and additional cerebral blood flow and hematocrit measurements.   Theory behind the 
QUIXOTIC technique is presented, including implications of velocity cutoff (VCUTOFF) and 
outflow time (TO) parameters.   Cortical gray matter Yv, OEF, and CMRO2 obtained with 
QUIXOTIC in ten healthy volunteers yield values of Yv = 0.73 ± 0.02, OEF = 0.26 ± 0.02, and 
CMRO2 = 125 ± 15 µmol /100g-min.   Results are compared to global measures obtained 
with the T2-relaxation-under-spin-tagging (TRUST) technique.   The preliminary data 
presented in this study suggest that QUIXOTIC will be a useful approach for mapping Yv, OEF, 
and CMRO2, in both clinical and functional MRI settings. 
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3.2 Introduction 
The rate of oxygen consumption in brain cells is known as the cerebral metabolic rate of 
oxygen (CMRO2) and is an important indicator of brain health and function (2).  As oxygen is 
not produced endogenously in the brain, it must be continuously supplied to meet metabolic 
demands.  Cerebral blood flow (CBF) fulfills this requirement by delivering oxygen via 
hemoglobin, the principal oxygen carrier in the body.  The ratio of oxygen consumption to 
oxygen delivery is called the oxygen extraction fraction (OEF) and, like CMRO2, also reflects 
brain health and function.  OEF can be expressed in terms of CMRO2 and CBF (60,62) in the 
following manner:  
 [ ]
2
total a
CMROoxygen consumptionOEF
oxygen delivery Hb CBF Y
= =
⋅ ⋅
 [11] 
where [Hbtotal] is the total concentration of hemoglobin in blood, and Ya is the arterial oxygen 
saturation.   
One of the main difficulties in measuring OEF and CMRO2 with in vivo 
1H MRI is the lack 
of a direct contrast mechanism.  However, since hemoglobin modulates MR signal relaxivity 
based on degree of oxygen saturation (Y), the possibility to indirectly assess OEF and CMRO2 
arises.   Venous oxygen saturation (Yv) can be extrapolated from the MRI signal and used first 
to compute OEF (62):   
 a v
a
Y YOEF
Y
−
=  [12] 
where arteriolar blood is assumed fully saturated (Ya = 1) or measured independently by 
pulse oximetry.  Following equation [11], CMRO2 is then calculated from OEF and additional 
CBF and hematocrit measurements. Since oxygen is typically extracted as blood traverses 
the capillary network, Yv measurements focused at the distal end of the network (i.e. in post-
capillary venlues) will yield spatially specific OEF and CMRO2 estimates.   
One class of methods to measure Yv implements an intravascular T2-based approach.  
This approach utilizes a theoretically and empirically derived relationship between blood 
  
62
transverse (T2) relaxation time (an MRI-specific parameter) and blood oxygen saturation (Y) 
(60).  Specifically measuring Yv requires selective targeting of blood in the venous circulation, 
without partial voluming with tissue, CSF, or other brain constituents. Isolating this pure 
venous blood signal, however, has been a major challenge for existing techniques,  
As a consequence, strict selection criteria must be used to identify voxels containing 
venous blood exclusively.  Methods presented by Oja et al. (62) and Golay et al.(63), for 
example, require functional activation experiments to identify candidate voxels, and of 
these, only a subset can be used.  Because of resolution limitations, these voxels are typically 
found only in larger venous vessels.  Since blood oxygenation in these larger vessels 
represents oxygen exchange of all supplying capillaries in large surrounding regions, these 
techniques have fundamental limitations on spatial specificity.  Voxel-wise Yv is 
unfortunately not feasible.   
More recently, Hu et al. have proposed T2-Relaxation Under Spin Tagging (TRUST) MRI 
and measure Yv in the sagittal sinus (64).  TRUST-MRI delivers a pure blood signal, free from 
partial volume effects, by using a spin-labeling approach to eliminate static tissue and CSF 
via control-tag subtraction.  While TRUST is an important advance for T2-based, Yv 
methodology, only global estimates are possible, since blood signal is isolated from the only 
largest cerebral veins (e.g. the sagittal sinus).  As such, TRUST Yv measurements are limited 
to these terminal, draining veins, and regional Yv information is lost. 
Our work utilizes the intravascular T2-based approach, but addresses the largest 
obstacle for localized measurements: the isolation of post-capillary venular (PCV) blood 
signal.  A novel excitation scheme is proposed that uses velocity-selective spin labeling to 
isolate PCV blood signal.  In principle, the methodology uses velocity-sensitive pulses to 
exploit heterogeneous blood velocities and unidirectional flow in the vascular tree and 
create a flow-dependent venular blood component that persists after control-tag 
subtraction.  This sequence incorporates T2-preparation-based technology, acquires PCV-
blood-weighted images at effective echo times, and exponentially fits these data to estimate 
post-capillary-venular blood T2.  T2,blood versus Y curves (with hematocrit as an independent 
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parameter) are then generated from theoretical models and existing 3T data and are used to 
calibrate PCV-blood T2 to Yv.  OEF is then estimated from Yv and combined with CBF 
(measured with arterial spin labeling MRI) and hematocrit to quantify CMRO2.  This new 
approach is dubbed QUantitative Imaging of eXtraction of Oxygen and TIssue Consumption 
or “QUIXOTIC”. 
We performed QUIXOTIC and TRUST MRI on ten healthy subjects and compare cortical 
gray matter measures of T2, Yv, OEF, and CMRO2 by QUIXOTIC, with global values estimated 
by TRUST.  
3.3 Theory 
3.3.1 Venular-targeted velocity-selective spin labeling 
The key innovation behind the QUIXOTIC approach is venular-targeted velocity selective spin 
labeling (VT-VSSL).  VT-VSSL allows targeting of MR signal exclusively from the PCV blood 
compartment, from which T2,and Yv can be measured.  VT-VSSL applies velocity-sensitive MR 
pulses to exploit differential velocities and accelerations of blood in the vascular tree, and 
relies on unidirectional flow from arteries, through capillaries, to veins.  The two-step data 
acquisition paradigm creates control and tag images with and without the desired venular-
blood component, respectively. Subsequent pairwise control-tag subtraction eliminates 
signal from static tissue, CSF, and non-venular blood compartments, leaving an image 
exclusively containing blood in the post-capillary venules.  The following section describes 
the details and timing behind this approach. 
QUIXOTIC is adapted from velocity-selective arterial spin labeling (65), and employs 
similar velocity selective (VS) modules to saturate blood spins above a given cutoff velocity. 
The pulse sequence is summarized schematically in Figure 3-1 and executed for both tag and 
control acquisitions. 
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Figure 3-1.  QUIXOTIC pulse sequence timing diagram.  Sequence is played once for control image generation, 
and repeated for tag image generation.  What differs between control and tag acquisition is velocity 
weighting in the Velocity Selective Module 2/ T2-prep module. 
The details of the VS module are presented in Figure 3-2.  
 
Figure 3-2.  Velocity selective module:  real (blue) and imaginary (red) RF waveforms (top) and gradient 
waveform (bottom).   Degree of velocity weighting (i.e. the velocity cutoff, Vc) is defined by the gradient 
strength (G), gradient duration (δ), and gradient separation (∆).  Disabling velocity selectivity implies G = 0.   
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The difference between the tag and control acquisition lies in the second velocity selective 
module.  While the tag acquisition applies a user-defined cutoff velocity (VCUTOFF) for both VS 
Module I (VS1) and VS Module II (VS2), the control uses VCUTOFF for VS1, but disables velocity 
selection for VS2 (i.e. moving spins are unaffected, VCUTOFF = infinity). Incorporated into VS2 
is a T2-preparation module (66) (80), allowing T2 estimation via data acquisition at multiple 
echo times. An important feature of the sequence is an inversion pulse at TO1, which 
compensates for adverse effects of T1 relaxation that could potentially introduce unwanted 
signal from arterial blood. 
To introduce properties of this sequence, we first neglect T1 relaxation and the TO1 
inversion pulse. Figure 3 provides an idealized cartoon depicting blood spins in the 
circulation for both control and tag acquisitions, their history during the pulse sequence 
timing, and the final spin contribution in the subtracted image.   At t=0, before VS1, all blood 
(arterial, venous, capillary) is relaxed (Figure 3-3a). Strong velocity weighting (low VCUTOFF) is 
then applied during VS1 for both tag and control, selecting for slow moving spins in small 
arterioles, capillaries, and small venules (V < VCUTOFF), but saturating (i.e. eliminating) faster 
moving spins in larger vessels (V > VCUTOFF) (Figure 3-3b).  Notably, this large-vessel signal is 
eliminated on both sides of the circulation. After VS1, the outflow time (TO) allows the 
targeted blood to flow out of the small vessel compartments and accelerate into larger 
venular vasculature (Figure 3-3c).  VS2 is then applied at TO.  This time, however, the tag and 
control acquisition experience different velocity weighting: the tag sees velocity selection at 
VCUTOFF, but the control experiences no velocity weighting.   Spins that have accelerated 
above VCUTOFF during TO are saturated by the tag acquisition, but left unaltered in the control 
(Figure 3-3d). As imaging starts immediately after VS2, subtraction of tag from control yields 
an image weighted to blood that has accelerated from below VCUTOFF, to above VCUTOFF during 
TO (Figure 3-3e). Assuming unidirectional flow (arterial to capillary to venous), these spins 
are venous-only. Other spins (static, CSF, non-venular blood) are eliminated via the 
subtraction. If VCUTOFF and TO are chosen properly, signal from PCV blood is exclusively 
targeted.   
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Figure 3-3.  Idealized cartoon of venular-blood signal targeting in QUIXOTIC approach, as told via spin 
configuration throughout the experiment.  Relaxed spins are denoted by upright arrows; saturated spins by 
hollow circles.  Dotted vertical lines correspond to 1 cm/s blood velocity (i.e. the cutoff velocity in B and D).     
T1 relaxation complicates this idealized model. Spins saturated by VS1 at t = 0 
experience longitudinal magnetization recovery. Because velocity selection via VS2 occurs 
only for the tag but not control, spins from unwanted compartments will partially recover in 
the control, but fully saturate in the tag at TO.  Without compensation, these unwanted 
spins will not subtract completely, and QUIXOTIC loses venous selectivity. We place an 
inversion pulse at time TO1 to null recovering blood at TO, so spins in this unwanted 
population are saturated in both control and tag at TO, leaving only desired PCV blood upon 
subtraction.  
 To generate the PCV blood-weighted maps at different echo times, T2-preparation is 
integrated into the VS2 pulse train.  This is done by inserting an additional pair of adiabatic 
180° pulses between the flip-up 90° pulse and first VS gradient lobe, for each successive 
effective echo time (TEeff), but at the same time keeping the timing of the readout EPI onset 
the same regardless of TEeff.  Using T2-preparation and fixing the EPI module in the timing 
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table makes the T2-encoding flow-insensitive; in other words, images at successive TEeff 
should differ only by T2-weighting, not by volume of spins delivered during TO (66).   
In principle, signal intensity in these blood-weighted images can be plotted versus TEeff, 
and subsequently fit on a voxel-by-voxel basis to create T2 maps specific to post-capillary 
venular blood.  T2 values can then be related to Yv and equations [11] and [12] can be used 
compute CMRO2 and OEF.   
3.3.2 T2-estimate: determination of effective echo times (TEeff) 
Unbiased estimate of T2 from SI versus TEeff curves depends on accurate estimate of TEeff at 
each successive acquisition.  Ideally, TEeff is equal to the duration of the T2-preparation 
module, which assumes pure T2-relaxation and very short refocusing pulses.  In practice, 
however, magnetization does not experience pure T2 decay during the hyperbolic secant 
refocusing pulses (66), and further, despite a long TR (4 s), a small amount of residual T1 
contamination is present from spins that have not completely relaxed.  To reduce the impact 
of such biases to the T2 estimate, we derived a small adjustment to the nominal echo spacing 
and apply the resulting effective echo spacing, ∆TEeff, for T2 estimation from the measured 
data. We simulated the pulse sequence using the Bloch equation, assumed T1 and T2 decay 
during the hyperbolic secant refocusing pulses, and estimated the ∆TEeff appropriate for our 
pulse sequence to minimize bias in the T2 estimate of venous blood.   The T1 and T2 used for 
the simulation were 1660 ms and 70 ms, respectively, which are approximate T1 and T2 
values for deoxygenated blood at 3T (64,67).  A similar simulation and adjustment was 
performed for the TRUST pulse sequence.  
3.3.3 T2,blood vs. Y Calibration 
The relationship between transverse relaxation time of blood and blood oxygen saturation 
(Y) was first examined in the early 1980s, by Thulborn et. al. (11).  In years following, a 
parametric model based on the Luz-Meiboom model of spin relaxation during two-
compartment exchange (in this case, between plasma and the red blood cell) was derived to 
fit experimental data measuring variations of T2,blood
 and blood oxygen saturation.  Such work 
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enabled MRI-based measurements of oxygen saturation in vivo (12).  In 1998, Van Zijl et al. 
proposed fundamental theory for T2-based signal changes in perfused tissue and presented a 
quantitative model linking T2 relaxation of blood to physiologic parameters including Y 
(60,63). This expression can be written in terms of T2, blood, Y, and Hct in the following form: 
 ( )( ) ( ) ( )( )2
2,blood
1 A Hct B C 1 Y 1 Hct D E 1 Y
T
ª º
= + ⋅ + − + − + −¬ ¼  [13] 
where A, B, C, D, and E represent lumped biophysical parameters related to susceptibility 
differences between the red blood cell and plasma, water relaxation rates in the red blood 
cell and plasma, and the spacing between 180° radiofrequency pulses in a CPMG spin-echo 
module (τCPMG). 
Fit of available Y versus T2,blood data at 3T obtained from in vitro bovine blood (3T, CPMG 
multi-echo T2 sequence, τCPMG = 10 ms, courtesy of P. van Zijl and C. Clingman, Johns Hopkins 
University), yielded values the for A, B, C, D, E, that we used in our work.  Using these values, 
Y versus T2 curves (with Hct as an independent parameter) were generated.  
3.3.4 Calculation of CMRO2 from Yv 
Once Yv is obtained, CMRO2 and OEF can be calculated by using equations  [11] and [12], 
with the final hematocrit measurement used to calculate the total hemoglobin 
concentration:  
 [ ]tot HctHb 3.0 (ml/g) 0.016125 (g/ȝmol)= ⋅  [14] 
3.4 Methods 
QUIXOTIC was used to evaluate Yv, OEF, and CMRO2 in healthy volunteers.  The protocol was 
approved by the University’s Committee of Using Humans as Experimental Subjects.  Ten 
young (22 to 32 years) non-smoking, healthy subjects (6 female, 4 male) were scanned at 3T 
(Siemens Tim Trio, Erlangen, Germany) with the following MRI protocol:  
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1) T1-weighted MP-RAGE image for anatomical localization:  voxel size = 1 mm3, matrix 
size = 256x256x68, acquisition time = 4 min 32 s. 
2) VT-VSSL blood-weighted imaging:  VCUTOFF = 2.0 cm/s (G = 1.6 G/cm, ∆ = 17 ms, δ = 2 
ms, τ180 = 10 ms) , x-directed, TO1=400 ms (assuming T1,blood = 1664 ms at 3T [3]), TO = 
725 ms, τCPMG of T2-preparation module = 10 ms.  A GRE-EPI readout was used for 
both tag and control image acquisitions:  TE = 12 ms, Phase Partial Fourier 6/8, BW = 
2232 Hz/pixel, matrix size = 64x64, single slice, voxel size = 3.9x3.9x10 mm3, TR = 4 s.  
Eighty measurements were acquired (40 control, 40 tag images), for an imaging time 
of 5 min 30 s per TEeff.  Either five or six TEeffs (depending on SAR constraints) were 
acquired with a ∆TEeff = 18.4 ms. 
3) Pulsed ASL CBF imaging:  PICORE/ Q2tips (81), TI1 = 700 ms, TI1 stop time = 1400 ms, 
TI2 = 1600 ms, PASL gap = 10 mm, Tag thickness = 160 mm, TR = 2000 ms, one slice, 
60 measurements, acquisition time = 2 min.  EPI parameters are as listed for 3).  M0 
calibration scan had identical imaging parameters, except ASL-specific pulses were 
disabled, and only one measurement was acquired.  
4) Double Inversion Recovery (DIR) for gray-matter-only images:  TI1 = 3700 ms, TI2 = 
4280 ms, one slice, one measurement, with EPI parameters as listed in 3). 
5) TRUST sagittal sinus blood imaging:  tag thickness = 50 mm, gap = 10 mm, TI = 800 
ms, TR = 8 s, 8 measurements per TEeff were acquired, ∆TEeff = 18.0 ms, one slice.  EPI 
parameters and T2-preparation are as listed for 3).    
Automatic alignment routines (82) were used to ensure similar slice placement among all 
subjects.  A slightly oblique-axial slice-of-interest was prescribed immediately superior to the 
corpus callosum for acquisitions 2 to 4, and contained a significant fraction of gray matter.  A 
different oblique-axial slice intersecting the sagittal sinus was positioned for acquisition 5 
(TRUST). 
Venular-blood-weighted imaging comprised the bulk of the scan session and the 
imaging time for the full protocol was less than an hour. Data were acquired at six TEeffs if 
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possible, but in four subjects, specific absorption rate constraints imposed a limitation of 
only five TEeffs.  To test the reproducibility, we performed the VT-VSSL experiment twice on 
two of the volunteers.  These volunteers remained in the scanner for an additional 30 
minutes for the second VT-VSSL acquisition.  The two VT-VSSL trials were spaced 
approximately half an hour apart and used identical scan parameters. 
 After MRI scanning, hematocrit was measured via finger prick blood sample using the 
Ultracrit device (Separation Technologies, Altamonte Springs, Florida).  O2 saturation was 
measured with a pulse oximeter (8600FO Pulse Oximeter, Magmedix, Fitchburg, MA).  
The data from each TEeff acquisition were corrected for bulk motion and then 
subtracted, control minus tag, in a pairwise fashion. The subtraction series was averaged to 
produce mean PCV-weighted images.  The DIR image was used as a gray matter (GM) mask, 
within which venular blood signal intensity (SI) from cortical GM tissue was measured.  PCV-
blood signal intensities from the entire cortical GM ROI were plotted versus TEeff to provide 
whole-slice cortical GM measurements.  The plots were then exponentially fit to measure 
the T2 relaxation parameter for whole-slice cortical GM.   
The TRUST acquisitions were similarly subtracted in a pairwise fraction, and averaged to 
produce maps containing sagittal-sinus-only blood at the five TEeffs.  The mean signal 
intensity from the six brightest sagittal sinus voxels blood was plotted versus TEeff and fit to 
estimate sagittal-sinus blood T2.     
T2 values from both VT-VSSL and TRUST analyses were then calibrated to Yv using curves 
generated with equation [13], incorporating the hematocrit measured from the volunteer.  
Since VT-VSSL data derive mostly from blood in small vessels, the T2 vs. Y calibration was 
calculated using the microvascular hematocrit (i.e. by multiplying the measured hematocrit 
by 0.85 to correct for hematocrit differences between small and large vessels (77)).  This 
correction was not needed for the TRUST calibration curves, as the source of venous blood 
was exclusively from the large sagittal sinus. Ya was taken as the oxygen saturation measured 
with the pulse oximeter; equation [12] was then used to calculate OEF.   
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To obtain CMRO2 from equation [11], CBF was estimated by ASL MRI, with a VT-VSSL-
matching slice prescription.  The ASL data were similarly analyzed to generate blood-flow-
weighted images, including subtraction, motion correction and signal averaging.  These 
images were calibrated to absolute CBF maps by using the local tissue proton density 
provided by the M0 scan (79).   GM CBF was estimated from the region segmented by the 
DIR GM mask.  WM CBF was estimated from the remaining, non-segmented brain region.  
The WM and GM CBF values were used to calculate whole brain (WB) CBF, by assuming a 
whole-brain WM:GM ratio of 0.675:1 (83).  With these additional CBF measurements, and by 
using hematocrit to estimate [Hbtotal], both QUIXOTIC (GM) and TRUST (whole brain) CMRO2 
were respectively calculated. 
All data processing was done in Neurolens (www.neurolens.org) software and with 
custom Matlab (Mathworks, Natick, MA) routines. 
3.5 Results 
Figure 3-4 shows the mean difference images for the VT-VSSL and TRUST acquisitions at five 
effective TEs for a representative subject. The signal in the VTVSSL images is our estimate of 
the post-capillary venular blood, which decays with a T2 time constant that depends on the 
blood oxygenation level.  
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Figure 3-4.  TRUST (top) and QUIXOTIC (bottom) mean difference images from representative subject.  Mean 
difference images are an average of many control-tag subtractions and reflect sagittal-sinus-blood-weighting 
in TRUST and venular-blood-weighting in QUIXOTIC. 
Figure 3-5a and b show the ASL-CBF map and the GM mask, respectively.  Figure 3-5c 
displays the slice orientation of the preceding acquisitions, overlaid on a high resolution mid-
sagittal section from the MP-RAGE scan.       
 
Figure 3-5.  Representative CBF image (a), double IR image (b), and anatomical MP-RAGE with prescribed 
slice overlay (c).  QUIXOTIC, ASL, and DIR sequences acquired data in this slice orientation. 
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Figure 3-6a shows the whole-slice-cortical-GM SI versus TEeff (QUIXOTIC) and sagittal 
sinus SI versus TEeff (TRUST) on a semilog scale for all subjects, including the fitted lines for T2 
estimates. All line fits had high R2 values: ш 0.95 for QUIXOTIC and ш 0.99 for TRUST. To 
improve the figure readability and highlight the relevant parameter (slope of line fits), the 
vertical offset of each line in each technique has been normalized.  The y-intercept estimates 
the volume of imaging spins within the sagittal sinus and gray matter voxels for TRUST and 
QUIXOTIC, respectively (but does not enter the OEF and CMRO2 estimates).   
Figure 3-6b shows calibration curves generated with equation [13] for the same subject.  
Values of A, B, C, D, and E for equation [13] were found as 1.09 s-1, 11.26 s-1, -7.96 s, 1.08 s-½, 
and 16.54 s-½, respectively.  Two curves are depicted for both microvascular and 
macrovascular hematocrit, to be used for QUIXOTIC and TRUST analyses, respectively.    
Lower hematocrit shifts the T2,blood vs. Y curve to the left, resulting in lower estimated oxygen 
saturations (Y) for a fixed measured T2,blood value.  
 
 
Figure 3-6.  a)  TRUST and QUIXOTIC log(Signal Intensity) versus effective TE curves and corresponding T2 fits 
for all ten subjects.  Vertical offset of the fit lines have been normalized for minimum variance within TRUST 
and QUIXOTIC datasets.  Solid blue and red lines represent mean T2-fit curves for all ten subjects, for TRUST 
and QUIXOTIC, respectively.  The vertical intercept estimates the volume of imaging spins within sagittal 
sinus and gray matter voxels for TRUST and QUIXOTIC, respectively.    
b)  Representative T2 versus Y calibration curves for Subject 1, generated at microvascular (red) and 
macrovascular (blue) hematocrit, using equation [13].  These curves are used to calibrate T2 to blood oxygen 
saturation for the QUIXOTIC and TRUST experiments. 
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Table 1 summarizes the measured blood relaxation times and the estimated 
quantitative physiological parameters for the ten subjects, i.e.  T2, Yv, OEF, CBF, and CMRO2. 
These values are shown for QUIXOTC (regional cortical GM and whole-slice cortical GM) and 
TRUST (whole brain).  The QUIXOTIC estimates were Yv = 0.73 ± 0.02, OEF = 0.26 ± 0.02 and 
CMRO2 = 125 ± 15 µmol of O2/(100g-min), while TRUST yielded Yv = 0.63 ± 0.02,  OEF = 0.36 
± 0.02, and CMRO2 = 125 ± 18 µmol of O2/(100g-min).  
Table 1. Summary of QUIXOTIC and TRUST data for all ten volunteers 
`  QUIXOTIC Cortical GM Parameters   TRUST Whole Brain Parameters 
Subject T2 (ms) 
GM CBF 
(ml/100g
-min) 
Yv OEF 
GM 
CMRO2 
(µl/100g-
min) 
 T2 (ms)
WB CBF 
(ml/100g
-min) 
Yv OEF 
WB 
CMRO2 
(µl/100g-
min) 
1 91 67 0.73 0.25 135   60 50 0.63 0.36 144 
2 84 55 0.70 0.29 124   59 40 0.62 0.37 116 
3 91 64 0.75 0.25 140   56 48 0.62 0.37 156 
4 83 52 0.72 0.25 113   55 37 0.62 0.35 117 
5 83 51 0.75 0.24 128   54 37 0.63 0.36 138 
6 90 65 0.73 0.26 141   66 48 0.66 0.33 131 
7 90 42 0.73 0.26 90   57 30 0.62 0.37 93 
8 86 57 0.71 0.29 125   58 40 0.62 0.38 118 
9 82 49 0.72 0.26 116   56 35 0.63 0.36 114 
10 86 55 0.76 0.23 135   63 37 0.68 0.32 124 
Mean 87 56 0.73 0.26 125   58 40 0.63 0.36 125 
STD  4 8 0.02 0.02 15   4 7 0.02 0.02 18 
CV 0.05 0.14 0.03 0.08 0.12   0.07 0.18 0.03 0.06 0.14 
 
Table 2 shows the intrascan test-retest data for Subjects 1 and 2, including the percent 
difference in the quantified parameters.  The differences were low in both cases: <1% for 
subject 1 and ч 5% for subject 2. 
Table 2.  Test-retest data for Subjects 1 and 2 
  Subject 1       Subject 2     
  Test Retest % Diff   Test Retest % Diff 
T2 (ms) 91 91 0.   84 80 5 
Yv 0.73 0.73 0   0.70 0.69 1 
OEF 0.25 0.25 0   0.29 0.30 3 
CMRO2  
(µmol/100g-min) 135 135 0   124 130 5 
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3.6 Discussion 
We have introduced a novel MR technique, QUIXOTIC, to quantify regional oxygen 
extraction fraction (OEF) and regional cerebral metabolic rate of oxygen (CMRO2), and have 
demonstrated its use in normal volunteers. Our estimates of OEF and CMRO2 fall within the 
expected physiological range and are comparable with those reported by other methods 
including PET (55,84-87), as suggested by Figure 3-7.  
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Figure 3-7.  QUIXOTIC and literature-reported cortical gray matter CMRO2. 
QUIXOTIC produces venular-blood maps by creating flow-derived signal from within the 
imaging voxel.  In principle, this property allows generation of venular-blood maps on a 
voxel-by-voxel basis.  By obtaining maps at several effective echo times (Teff), it is possible to 
fit for T2 and subsequently obtain voxel-wise measures of Yv, OEF, and CMRO2. A voxel-by-
voxel analysis of the data acquired in this study, however, yields unacceptably high variances 
and poor goodness-of-fit T2 measures, due to inadequate signal-to-noise ratio (SNR). As a 
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consequence, we did not report CMRO2 and OEF values on a voxel-by-voxel basis, but 
instead report quantifications based on an average of cortical gray matter voxels within a 
single slice.   
Two key parameters define the nature of the QUIXOTIC signal, and directly control its 
spatial specificity, SNR, and maximum SNR:   Velocity Cutoff (VCUTOFF) and Outflow Time (TO).  
When taken together, VCUTOFF and TO determine the extent of the velocity-selected bolus at 
imaging time by defining its trailing and leading edge, respectively, and subsequently the 
venular-blood component remaining in the subtracted image.   
3.6.1 Outflow time (TO) 
The outflow time TO of the QUIXOTIC experiment determines the SNR and spatial specificity 
of the subtracted venular-blood component.  During TO, blood spins accelerate above the 
VCUTOFF threshold and into receiving venular vasculature within the imaging voxel.  Imaging 
signal is created, and intensity increases as these spins begin to fill the imaging voxel.  The 
final signal intensity (SI) is directly proportional to the volume of spins that have accelerated 
above VCUTOFF during TO, while still remaining within the voxel (hereafter termed as “imaging 
spins”).  This final SI is directly proportional to SNR.  
As imaging spins disseminate through the tortuous venular microvasculature during TO, 
they flow deeper into the venous circulation, and the leading edge of the bolus travels 
further away from capillary sites of gas exchange.  As long as these spins do not leave the 
voxel, oxygen saturation within these pools properly represents oxygen exchange of their 
capillary sources.  Spatial specificity is perfectly preserved, and imaging spin volume is 
exactly the product of venular outflow and TO. 
As TO increases, however, imaging spins eventually leave their voxel of origin, and do so 
one in one of two ways:  1) clear through to the larger venous circulation outside of the 
imaging slice, or 2) clear through to larger venous vasculature in adjacent voxels but stay 
within the imaging slice.   These cleared spins do not contribute signal to the source voxel, 
and thus do not represent oxygenation within this voxel; in this respect, they can be 
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considered lost signal.  In the former case, cleared spins do not affect spatial specificity, 
since they have left the imaging slice entirely.  Spins in the latter case, however, will 
contribute to signal intensity of neighboring voxels.  Based on these phenomena, the lower 
the TO, the higher the spatial specificity. 
However, because SI (and therefore SNR) increases with TO, there is a trade-off 
between spatial specificity and SNR.  Both must be considered for optimal QUIXOTIC 
performance, and TO should be selected based on the SNR and spatial specificity 
requirements of the intended application.  In this way, it is possible to choose TO such that 
imaging spins will maximally occupy venules in the imaging voxel, with only a relatively small 
proportion having departed.  This optimal TO will lead to high SI, with only a marginal loss of 
spatial specificity.   Of note, blood T1-relaxation should also be considered when choosing 
TO, since longer TOs will result in substantial loss of signal due to T1 recovery.  
3.6.2 Velocity cutoff (VCUTOFF) 
VCUTOFF determines the maximum possible SNR of the venular-blood component in the final 
image, by defining the maximum available vascular volume that can be occupied by the 
venular bolus.    Since blood velocity is closely related to vessel caliber, VCUTOFF not only 
defines the cutoff blood velocity, but also determines how far into the venous vascular tree 
the trailing edge of imaged bolus is located.  A low VCUTOFF means that imaging spins originate 
closer to the distal end of the capillary bed, while a high VCUTOFF means that imaging spins 
originate closer to terminal draining veins.  As VCUTOFF increases, imaging spins originate from 
points farther along the venous vascular tree, effectively reducing the remaining vascular 
voxel volume that can be filled by these spins.  In this way, VCUTOFF sets a hard limit to the 
maximum volume of imaging spins that can occupy a voxel, with lower VCUTOFFs offering 
higher SI at the optimal TO.  A VCUTOFF just above capillary blood velocities is the ideal choice.  
A VCUTOFF lower than capillary velocities is undesirable for three reasons: 1) VS theory 
assumes laminar flow, not capillary plug flow (65), for proper velocity filtering,  2) as VCUTOFF 
decreases, the relaxed blood pool available to flow above VCUTOFF will at some point become 
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too small, also resulting in SNR reduction, and 3) when large velocity-weighting is applied, 
tissue or CSF water diffusion becomes a contaminating source of signal(65). 
Another way to model signal generation in QUIXOTIC is to visualize imaging spins 
emerging from many different spatial sources within the voxel.  The number and location of 
these sources is based on the spatial distribution of the voxel microvasculature and the 
VCUTOFF parameter choice.  At the theoretically ideal VCUTOFF (i.e. right above capillary blood 
velocities), there will be many sources scattered throughout the typical MRI gray-matter 
brain voxel, simply due to the high capillary density.  Imaging spins flow from these sources 
during TO, and at the optimal TO, will fill a large fraction of the voxel’s venular vasculature.  
As VCUTOFF increases, however, these points move further down the vascular tree and merge.  
This results in a reduction of source density and distal available vascular volume, both of 
which result in an SNR decrease.  At the extreme, VCUTOFF increases so much such that venous 
vessels within the voxel do not contain blood flowing below VCUTOFF.  The number of sources 
drops to zero, no imaging spins emerge, and the subtraction image is void of signal.    
Based on the above considerations and pilot data, we chose VCUTOFF = 2 cm/s and TO = 
725 ms.  These choices yield sufficient SNR in the final venular blood images for cortical 
analysis at 3T and maintain high spatial specificity. As seen in Figure 3-4, venular blood signal 
appears well-matched to cortical gyri, with minimal blurring.  This is best appreciated by 
comparing the venular-blood-weighted images to the CBF and DIR images in Figure 3-5.   
Two additional factors influenced the VCUTOFF decision in this experiment: 
1) While the VS pulse train imposes velocity selectivity, the same train applies a small 
degree of diffusion-weighting, which increases with lower VCUTOFF.  A VCUTOFF of 2 cm/s 
results in a b-value of approximately 1 s/mm2, which in prior VS-ASL experiments was 
deemed an acceptable value based on the minimal diffusion-weighting effects on the 
subtraction image   (65).  This assumption of negligible diffusion weighting may not 
hold as the VCUTOFF is further reduced. 
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2) The VS profile deviates from an ideal filter with the given cutoff velocity. For laminar 
flow (which can be safely assumed for VCUTOFF ranges considered here), a sinc 
function defines the fraction of spins that pass through the VS module as a function 
of velocity (65). As a consequence, some blood below the nominal 2 cm/s cutoff (and 
thus closer to exchanging capillary beds) is included in the filtered pool, resulting in 
the trailing edge of the final bolus to be even closer to the distal end of draining 
capillaries.  
In this initial demonstration of QUIXOTIC, we did not perform a comprehensive optimization 
for VCUTOFF and TO, but we expect future studies with empirically optimized imaging 
parameters to improve the performance of QUIXOTC.  Because voxel size defines the 
maximum venular blood volume, it is necessary to separately optimize VCUTOFF and TO for 
different imaging resolutions. 
As a final comment on the design choice of VCUTOFF, we describe a modification to 
QUIXOTIC that we term “Velocity Bracketing.”  Velocity Bracketing imposes a different 
VCUTOFF for the control VS2 module (which in this initial investigation was simply VCUTOFF = 
infinity) that is larger than the tag VS2 VCUTOFF.  The trailing edge of the bolus remains defined 
by the tag VS2 VCUTOFF , while the leading edge will be now defined by this new larger control 
VS2 VCUTOFF, termed VBRACKET.   By introducing this additional VBRACKET design parameter, the 
final subtracted bolus is now bracketed by these two velocity cutoffs and will be limited to 
blood within the bracket.  This application of Velocity Bracketing allows maximization of 
imaging spin volume via TO without sacrificing spatial specificity because of spin clearance. 
Additionally, imposing velocity selection for the control VS2 is expected to decrease diffusion 
contribution from tissue or CSF in the final subtraction images, since the difference between 
control and tag diffusion weighting will be much smaller than without Velocity Bracketing.  
The Velocity Bracketing refinement to QUIXOTIC offers additional flexibility to the technique, 
and is currently being investigated.  
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3.6.3 Comparison of QUIXOTIC and TRUST measurements 
Values of OEF and CMRO2 estimated with QUIXOTIC fall within the physiologic range, and are 
in good agreement with other PET and MR measures in the literature.  The key physiologic 
parameter measured by QUIXOTIC is local venular oxygen saturation Yv, which shows low 
measurement variability across ten subjects (CV = 0.03). Of note, however, is that the whole-
slice cortical GM Yv measurements by QUIXOTIC were significantly higher than sagittal sinus 
Yv measured with TRUST (0.73 versus 0.63 for QUIXOTIC and TRUST, statistically different at 
p < 0.00001 , paired t-test).  Moreover, the 95% CI for the true difference in Yv between the 
techniques lies between 0.08 and 0.11, suggesting a systematic bias between the two 
techniques.  This Yv discrepancy translates into a lower OEF for QUIXOTIC, compared to 
TRUST (0.26 versus 0.36).  Table 1 highlights theses differences, where whole-brain Yv 
measured with TRUST measurement is on average 14% less than the single-slice cortical GM 
Yv measured with QUIXOTIC.   
Several potential sources could contribute to this discrepancy in Yv as reported by the 
two methods.  First, TRUST measures Yv from the final draining vein of the cerebral 
circulation, the sagittal sinus.  At this stage of the circulation, oxygen exchange is complete, 
and blood will be at its lowest level of oxygenation.  In contrast, QUIXOTIC by design 
measures blood further upstream, including venules distal to draining capillary beds.  It is 
possible that oxygen extraction is still occurring in smaller venules; in other words, 
extraction could extend beyond just the capillary bed into the venous side of circulation.  
Such a phenomenon would result in the early venular blood to be more oxygenated than 
blood in terminal draining veins, and thus bias the VS bolus Yv measurement towards a 
higher level than in the sagittal sinus.  Differential oxygen saturations in different-caliber 
veins is have been recently explored (88) where probe-based oxygen sensing was used to 
measure PO2 in rat brain. In this study, it was found that medium-caliber pial veins (D=139 
µm) are substantially more oxygenated (up to 15% more) than small and large caliber pial 
veins (55 µm and 391 µm, respectively).  If a similar distribution holds true in human 
vascular physiology, blood from these medium-caliber vessels within the VS bolus would also 
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bias the overall oxygen measurement to a correspondingly higher value.  A more detailed 
investigation is required to determine if the Yv discrepancy between QUIXOTIC and TRUST is 
based on differential oxygen distributions across the vascular tree.  QUIXOTIC measurements 
with different VCUTOFF and TO parameters could in fact be used to probe this question.  
Other possible sources of bias originate from the QUIXOTIC technique itself.  Among 
them is contamination of the venular-derived VS bolus by arterial blood, which could 
manifest in at least two different ways.  As mentioned in the theory section, initially-
saturated arterial blood will experience T1-recovery after VS1.  In an effort to prevent this 
blood from giving rise to signal in the final subtraction, we inserted a single inversion pulse 
at a time TO1, which in theory should null this arterial component.  TO1 is based on an 
assumed T1,blood (67); if the true T1,blood differs significantly from this assumed value, the 
inversion null may not be effective, leading to an arterial contribution in the final subtracted 
signal.  Since the T2 of fully oxygenated arterial blood is larger than 150 ms (as empirically 
determined by PASL-based experiments using an identical T2-preparation module), a small 
fractional contribution of arterial signal could bias the measured T2, and subsequently Yv.  To 
explore this potential contamination source, we implemented and tested a double-inversion 
approach in QUIXOTIC, which dramatically improves nulling robustness and reduces signal 
across a much wider T1 range (but imposes an additional SAR penalty).  Comparing the 
single- and double-inversion variants of QUIXOTIC did not yield a substantial change in 
measured T2, leading us to conclude that arterial contamination by incomplete T1 nulling is 
not a dominant source of error.  
 Another possibility for arterial contamination could be attributed to the non-ideal 
velocity selection profile.  While the ideal velocity selective profile perfectly preserves signal 
from all spins below VCUTOFF and saturates all spins above VCUTOFF, the actual VS profile 
follows a sinc envelope as a function of spin velocity.  Consequently, the final VS bolus will 
also have a sinc-like shape, including side-lobes that extend into the arterial side of the 
circulation.  As TO increases, the VS bolus will move further into the venous circulation, and 
the side-lobes on the arterial side become smaller, resulting in less contamination.  We 
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explored this potential contamination source with QUIXOTIC measurements at three 
progressively longer TOs in a single subject.  No significant differences in Yv were observed, 
suggesting that this source of arterial contamination is not a large source of bias in 
QUIXOTIC. 
A third potential source of bias in Yv with QUIXOTIC is the small but inevitable diffusion 
weighting in the experiment.  The combination of gradient and RF pulses that allow velocity 
selection will at the same time lead to (mild) diffusion-weighting.  Since the control image 
acquisition involves turning off the gradients during VS2, the control image will not be 
diffusion-weighted, while the tag image will be slightly diffusion-weighted.  The subsequent 
subtraction map has some degree of diffusion-weighting, thus introducing both tissue and 
CSF components into the otherwise pure venular blood-weighted images.  This problem was 
explored by Wong and colleagues for VS-ASL (65) and in (89).  Both studies concluded that 
diffusion effects were minimal, due to the weak gradients (G), short gradient durations (δ), 
and large gradient separation (∆) used in the VS module.  In our specific experiments, b-
value was calculated to be ~1 s/mm2, leading to less than ~0.07% attenuation in tissue (Dtissue 
= 0.0008 mm2/s) and ~0.020% attenuation in CSF (DCSF =  0.0024 mm
2/s), given a fractional 
contributions of tissue and CSF of ~95% (90)and ~10% (91), respectively.  Given that the 
blood-weighted signal upon subtraction is roughly 2% of the original signal, we expect less 
than 4% error from diffusion effects at TEeff =0.  However, because the T2 of CSF is 
considerably longer than the T2 of deoxygenated blood, diffusion-based CSF effects could be 
become more prominent at longer effective echo times.  This potential source of error must 
be experimentally explored in future studies.   
An important practical difference between TRUST and QUIXOTIC is SNR. SNR is directly 
related to the volume of voxel imaging spins considered during acquisition and is 
represented by the vertical intercepts in figure 6a.  Because of the high fractional blood 
volume in the sagittal sinus (approximately 1), the volume of imaging spins is between 1-2 
orders of magnitude greater in TRUST, compared to QUIXOTIC.  In this way, TRUST has major 
a SNR advantage, affording substantially shorter imaging times and higher precision fits.         
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3.6.4 Future work 
Future work will primarily focus on methods to improve QUIXOTIC SNR and reduce imaging 
time.  Multi-echo readout will be an immediate modification explored in future 
implementations.  In this preliminary study, T2-preparation was used to make the sequence 
insensitive to flow effects.  However, because the targeted blood velocities are slow (e.g ~2 
cm/s) compared to the inter-echo spacing of 20 ms, flow effects between echoes of a multi-
echo readout in QUIXOTIC are expected to be minimal.  Such an approach would acquire all 
echoes in a single scan, and allow even more than just the five or six collected here.  
Additionally, since all echoes are acquired per measurement, we expect bulk motion and 
physiological artifacts to be reduced, leading to better quality data and improved fits.  We 
anticipate at least a five-fold decrease in minimum imaging time, dropping the QUIXOTIC 
scan time to between 4 and 7 minutes (including ASL). This dramatic increase in imaging 
speed will make the technique more amenable to  functional MRI, since the TEeff image 
series will be generated every two TR, allowing an image time course to be acquired; and 
clinical MRI, since patients will better tolerate a shorter scan.  Additionally, a more detailed 
exposition of the TO and VCUTOFF parameter space will facilitate application-specific 
optimization, and further our understanding of the technique in general.  Finally, a multi-
echo readout can result in a significant increase in SNR for fixed total scan time by acquiring 
more images per TEeff time point and averaging.   
In this study velocity selection was applied in a single direction (x).  Consequently, spins 
flowing along y- and z- axes are unaffected and will subtract in the final image, regardless of 
velocity.  An additional improvement will encode velocity along all three spatial dimensions.  
Encoding in three dimensions will require a longer and more complicated VS pulse train, but 
will increase final SI (and thus SNR) by up to a factor of three.   
We expect multiecho and multi-dimension velocity selective approaches to make 
regional and voxel-by-voxel measurements considerably more feasible, especially at higher 
field strengths (e.g. 7 Tesla).  In this way a greater scope of applications in both disease and 
functional neuroscience will be realized.   
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3.6.5 Conclusion 
QUIXOTIC MRI introduces a novel approach to isolate PCV blood signal and 
subsequently measure cortical GM Yv, OEF, and CMRO2.  Values reported for Yv, OEF, and 
CMRO2 are comparable with those acquired by other PET and MR studies, and fall within a 
normal physiological range.  Advantages of QUIXOTIC include: 1) QUIXOTIC maps blood in 
the venous circulation only, with CSF, static tissue, and capillary/arterial blood eliminated; 2) 
subject to SNR constraints, QUIXOTIC analysis can be performed on a voxel-by-voxel basis, 
allowing creation of Yv, OEF, and CMRO2 maps; and 3) QUIXOTIC generates images every TR, 
making the technique amenable to functional imaging of Yv and OEF during block-design and 
event-related fMRI.  To our knowledge, no currently available technique offers all three 
features. Future studies will explore optimal parameter settings, employ a multi-echo 
readout for rapid data acquisition and multi-directional velocity weighting for increased SNR, 
enable Velocity Bracketing for improved venular blood selectivity and SNR, and deploy 
QUIXOTIC at higher magnetic fields.  
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Chapter 4  
Effect of hypercapnia on cortical cerebral 
metabolic rate of oxygen (CMRO2) in awake 
humans as assessed by QUIXOTIC-MRI 
4.1 Abstract  
Hypercapnia via carbon dioxide (CO2) inhalation is used to increase cerebral blood flow (CBF) 
in a variety of clinical and research applications.  While the effects of CO2 on CBF have been 
well identified, far less understood are the effects of CO2 on the cerebral metabolic rate of 
oxygen (CMRO2).   In this study, a recently developed method called QUantitative Imaging of 
the eXtraction of Oxygen and TIssue Consumption (QUIXOTIC) is used to evaluate cortical 
gray matter CMRO2 in response to mild hypercapnia in awake humans.  It was found that 
cortical CMRO2 decreased significantly (paired t-test, p = 0.036) by 26 ± 14% on average.  
This reduction arises from a more pronounced decrease in oxygen extraction fraction (1.8x, 
or 44 ± 13%), compared to CBF increase (1.3x, or 33 ± 9%), as the product of these 
parameters is directly proportional to CMRO2.  A new cerebral metabolic reserve (CMR) 
parameter is introduced to quantify ∆CMRO2:∆ETCO2 and is related to the extent CMRO2 can 
decrease without functional impairment.   Implications of CMRO2 depression and relevance 
of CMR are discussed, with regards to clinical and functional neuroactivation studies.  
4.2 Introduction 
Carbon dioxide (CO2) is a powerful vasodilator, capable of directly and globally increasing 
cerebral blood flow (CBF) in the absence of external sensory stimulation.  Because of its high 
potency, only small, benign concentrations are needed for large CBF effects, making CO2 
delivery to humans safe, easy, and practical in clinical and research environments.   
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From a clinical standpoint, carbon dioxide inhalation has shown potential for several 
applications.  Studies pertaining to stroke, cerebral ischemia, and carotid artery stenosis 
induce mild hypercapnia to evaluate so-called cerebral vascular reserve (CVR), the ratio of 
∆CBF to ∆end-tidal CO23.  One such study has shown that CVR impairment within the first 24 
hours of acute stroke is significantly associated with end neurological deterioration (92).  In 
more chronic scenarios, CVR has been identified as 1) an independent risk factor for stroke 
or transient ischemic attack in patients with carotid artery stenosis (93), 2) a predictor of 
recurrent stroke in patients awaiting carotid revascularization endarterectomy (94), and 
most recently, 3) a risk factor for future events, post-endarterectomy (95).  Of note, these 
studies all use blood oxygen level dependent (BOLD) magnetic resonance imaging (MRI) to 
evaluate CBF response to CO2-challenge and calculate CVR.  In addition to prognostic 
benefits of hypercapnia-based measurements (like CVR), a recent report has investigated 
therapeutic potential of hypercapnia in ischemia, with specific regards to occlusive carotid 
artery disease (CAAD)(96).  Administering mixtures of CO2 and O2 (typically called carbogen) 
to CAAD patients was shown to increase oxygen transport to hypo-perfused areas of the 
brain (compared to O2 alone) suggesting utility for CO2 in acute stroke treatment.   
Effects of carbon dioxide on tumor pathophysiology are also of interest to the clinical 
community.  Tumor hypoxia is associated with decreased sensitivity to radiotherapy, since 
hypoxia provides an overall positive survival advantage for malignant growth (97).  Carbogen 
mixtures have been used to alleviate hypoxia of intracranial tumors, with both BOLD MRI 
and electron paramagnetic resonance oximetry confirming that carbogen increases brain 
tumor oxygenation, presumably by reducing diffusion-limited hypoxia via O2, and perfusion-
limited hypoxia via CO2 (98,99).  Trials such as ARCON, which uses a combination of 
nicotinamide and carbogen to boost tumor oxygenation, have subsequently been successful 
                                                      
 
3 End-tidal CO2, or ETCO2, is an easily measurable surrogate of blood pCO2 and, as such, increases during 
hypercapnia. 
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in increasing tumor susceptibility to radiotherapy (100); it is further hypothesized that 
hypoxia modification may enhance efficacy of chemotherapy as well (101).   
While large-scale clinical utility of carbon dioxide remains to be seen, hypercapnia has 
arguably found greater relevance in the rapidly growing field of functional MRI (fMRI).  
Nearly all fMRI studies are conducted using the BOLD technique, which achieves functional 
contrast by recording a single signal that indirectly measures changes in CBF, cerebral blood 
volume (CBV), and cerebral metabolic rate of oxygen (CMRO2), all of which are related to 
brain function (102).  It has been suggested, however, that neural activity may be most 
tightly coupled to CMRO2, both spatially and temporally (18).  As such, a significant goal of 
fMRI development has been to resolve CMRO2 from the BOLD signal.  To achieve this, a 
“calibrated” BOLD technique was recently introduced that uses hypercapnia induction to 
extrapolate relative CMRO2 from the BOLD signal (40).  The key assumption in calibrated 
BOLD is that CO2-challenge increases CBF, without affecting CMRO2;  by subsequently 
measuring BOLD and CBF signals during hypercapnia, and normalizing to the alleged CMRO2-
independent CBF change, relative CMRO2 during functional challenges can be estimated.  
The validity of CMRO2-independence, however, is not completely clear.  
In sum, both clinical and functional applications of hypercapnia exploit CBF changes 
produced by hypercapnic challenge.  However, while the vascular effects of CO2 have been 
well identified and studied, far less understood are the effects of CO2 on neuronal activity 
and cellular metabolism, including CMRO2.  The aforementioned applications tend to ignore 
metabolic and neuronal changes, or assume that they are negligible in the brain.  In reality, 
however, if significant CMRO2 changes do occur during hypercapnia, the efficacy of such 
applications could decrease, or at the least, be altered.  Furthermore, if neuronal and 
metabolic changes are heterogeneously related to flow change, they could possibly explain 
some of the variability in CO2-based studies, especially with regards to clinical outcomes and 
relative CMRO2 measures in calibrated BOLD.   As such, investigating and understanding how 
CMRO2 in response to hypercapnia is essential for moving forward.   
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Early studies examining neurophysiological parameters during hypercapnia 
(42,44,103,104) suggested that CO2 was purely vasoactive and did not alter neuronal activity 
or oxygen metabolism.  More recent evidence has suggested that this may not be the case.  
Two recent electrophysiological studies in animals (anesthetized rats and nonhuman 
primates) recording neuron ensemble input and output activity during hypercapnia 
produced contradictory results; one study showed a marked decrease in cortical activity 
(46), while the other reported an increase in cortical activity (105).  An Two MRI-based 
studies evaluated global CMRO2 in awake humans during CO2-challenge, and also report 
contradictory findings of CMRO2 reduction (45) and CMRO2 stasis (106).  Clearly, neuronal 
and metabolic effects during hypercapnia have yet to be definitively answered, necessitating 
additional investigation and techniques for evaluation.    
Recently we introduced a new MRI technique amenable to quantitative evaluation of 
cortical CMRO2 during normocapnia and hypercapnia.  The technique has been dubbed 
QUantitative Imaging of the eXtraction of Oxygen and Tissue Consumption, or QUIXOTIC, 
and was originally presented in (107).  Details of the QUIXOTIC methodology have been 
described in the aforementioned reference; in short, the technique uses velocity-selective 
spin labeling to create image maps weighted to post-capillary venular blood.   By acquiring 
these images at multiple echo times, is possible to measure the T2 of this venular-blood 
component, which can be calibrated to venular blood oxygen saturation (Yv) via theoretical 
and empirical relationships between T2,blood and oxygen saturation (11,12,60).  Yv is then 
converted to oxygen extraction fraction (OEF) with the following equation (62): 
 a v
a
Y YOEF
Y
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where Ya is the arterial oxygen saturation.  Arterial blood can be assumed to be fully 
saturated (i.e. Ya = 1), or measured via pulse oximetry.   CMRO2 is then subsequently 
calculated using the following equation (60,62): 
 2 total aCMRO OEF CBF [ Hb ] Y= ⋅ ⋅ ⋅  [16] 
where [Hbtotal] is the total hemoglobin concentration in blood (closely related to hematocrit) 
and CBF is cerebral blood flow, which can be measured with other MRI techniques.    
In this study, we use QUIXOTIC methodology to compute cortical gray matter (GM) CBF, 
Yv, OEF, and CMRO2 during mild hypercapnic challenge in healthy, awake human subjects.  
The goal is to better understand how these parameters are modulated by CO2 and test 
whether CO2-induced hypercapnia produces a CMRO2-independent CBF change, or if CMRO2 
is indeed altered.   Unique features of this study are that QUIXOTIC will be used to measure 
cortical-only changes in Yv, OEF, and CMRO2, and that arterial spin labeling (ASL) will be used 
to make CBF measurements.  It is generally agreed that ASL is the only MRI technique 
capable of quantifying CBF at the level of tissue perfusion (90).  To our knowledge, this is the 
first study to report cortical CMRO2 changes in awake humans during hypercapnia.  
Finally, we introduce a brand new parameter called cerebral metabolic reserve (CMR), 
which is the ratio of ∆CMRO2/ ∆ETCO2.  We report values of CMR measured during 
hypercapnia, discuss its qualitative meaning, and postulate that it will have important 
implications in future functional and clinical applications of QUIXOTIC-CO2. 
4.3 Methods 
4.3.1 Subjects 
Four healthy human volunteers were imaged at 3T (Siemens Tim Trio, Erlangen, Germany) 
during states of normocapnia and hypercapnia.  Informed consent was obtained from all 
subjects, and an additional CO2-specific screening form was incorporated to exclude subjects 
at increased risk of adverse reaction to CO2 inhalation.   Approved candidates ranged in age 
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from 26-31, and consisted of 2 males and 2 females.   The experimental protocol and 
recruiting procedures were approved by the University’s Committee on the Use of Humans 
as Experimental Subjects and operated within the established guidelines.    
4.3.2 Hypercapnia iInduction 
Mixtures of CO2 and compressed air were supplied via a gas delivery system comprised of 
digital flow controllers (Sierra Instruments, San Jose, California), custom mixing apparatus, 
and a custom-built breathing circuit.  The flow controllers are designed to provide accurate 
and constant gas flows, independent of pressure or other fluctuations in the circuit.    At the 
receiving end is a custom-built re-breathing apparatus, with inflatable reservoir bag, and 
snorkel mouthpiece.  Of note, the first two subjects were delivered gas mixtures through a 
non-rebreathing circuit, consisting of a facemask (Hudson RCI, Research Triangle Park, NC).  
Such a setup, however, used considerable amounts of gas; the decision was thus made to 
use a non-rebreathing circuit for all subsequent subjects, primarily for gas conservation.   
Regardless of setup, ∆ETCO2 was kept relatively constant for the duration of the experiment 
and monitored via sample line connected to real-time CO2 gas analyzer (Capstar 100, CWE, 
Ardmore, PA).  Target ∆ETCO2 was between 6 mmHg, which results in mild hypercapnia in 
humans.   
Gas manipulations were first performed outside of the MRI scanner to 1) allow subjects 
to become familiar with the experimental setup and particulars of gas delivery, and 2) 
establish baseline physiological readings under normocapnia, 3) determine the required CO2 
concentrations and gas flow rates needed to establish a ∆ETCO2 increase of approximately 6 
mmHg, and 4) and ensure no adverse reactions to CO2. 
Subjects were initially delivered compressed air (79% N2, 21% O2) through the circuit; 
baseline readings of ETCO2 and respiratory waveforms were recorded.  After baseline 
readings of the above parameters were established, low concentrations of CO2 were added 
to the mixture, to produce a ∆ETCO2 of approximately 6 mmHg.  In addition to ETCO2, the 
subject’s blood pressure and heart rate were continually monitored.  The subject was 
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instructed to relax and breathe freely.  With successful completion of this training, the 
subject was moved into the MRI scanner for imaging, and the gas delivery apparatus was 
replaced. 
4.3.3 MR Imaging 
QUIXOTIC methodology was used to evaluate Yv, OEF, and CMRO2 during normocapnia 
(subject breathing compressed air) and hypercapnia (subject breathing CO2/air mixture).  
During the entire scan ETCO2, heart rate, and arterial oxygen saturation (Ya) were monitored.  
Ya and heart rate were monitored via pulse oximeter (8600FO Pulse Oximeter, Magmedix, 
Fitchburg, MA).  The subject was delivered compressed air for the first half of the scan 
period, after which he or she was switched to the CO2/air mixture.  
Four classes of MRI scans were performed:  
1) T1-weighted MP-RAGE image for anatomical localization:  voxel size = 1 mm3, matrix 
size = 256x256x68, acquisition time = 4 min 32 s,   
2) QUIXOTIC venular blood-weighted imaging:  Cutoff velocity = 2.0 cm/s, x-directed, 
TO1= 400 ms (assuming T1,blood = 1664 ms at 3T (67)), TO = 725 ms, τCPMG of T2-
preparation module = 10 ms.  A GRE-EPI readout was used for tag/control image 
acquisition:  TE = 12 ms, Phase Partial Fourier 6/8, BW = 2232 Hz/pixel, matrix size = 
64x64, single slice, voxel size = 3.9x3.9x10 mm3, TR = 4 s.  Eighty measurements were 
acquired (forty control, forty tag images), for an imaging time of 5 min 30 s per TEeff.  
Four TEeffectives were acquired with a ∆TEeffective = 18.4 ms. 
3) Pulsed ASL CBF imaging:  PICORE/ Q2tips (81), TI1 = 700 ms, TI1 stop time = 1400 ms, 
TI2 = 1600 ms, PASL gap = 10 mm, Tag thickness = 160 mm, TR = 2000 ms, one slice, 
60 measurements, acquisition time = 2 min.  EPI parameters are as listed for 3).  M0 
calibration scan had identical imaging parameters, except ASL-specific pulses were 
disabled, and only one measurement was acquired.  
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4) Double Inversion Recovery (DIR) for cortical-GM-only images:  TI1 = 3700 ms, TI2 = 
4280 ms, one slice, one measurement, with EPI parameters as listed in 3). 
For all subjects, automatic alignment routines (82) were used to ensure similar slice 
placement; the slice-of-interest was prescribed superior to the corpus callosum, and thus 
contained mostly GM.   
The imaging protocol was run once during the normocapnic period and exactly repeated 
during hypercapnia, with the exception of the MP-RAGE.  The MP-RAGE scan was placed in 
the middle of the experimental protocol; at the beginning of the MP-RAGE, the subject was 
switched from compressed air to the CO2/ air mixture.   The four and a half minute duration 
of the MP-RAGE scan was enough to allow any fine adjustments to flow rates (and thus 
%CO2 contribution) to achieve the desired ∆ETCO2, and at the same time, allow steady-state 
to be reached.  
After MRI scanning, hematocrit was measured via finger prick blood sample using the 
Ultracrit device (Separation Technologies, Altamonte Springs, Florida).   
4.3.4 Data Analysis 
Raw data series from each TEeff acquisition were corrected for motion, then subtracted in a 
pairwise fashion. The subtraction series was averaged to produce mean venular-blood-
weighted images.  The DIR image was used as a GM overlay, from which venular-blood signal 
intensity (SI) from GM tissue could be measured.  Venular-blood SIs from the entire GM ROI 
were plotted versus TEeff to provide cotical GM measurements.  The plots were then 
exponentially fit to measure the T2 relaxation parameter for cortical GM.  For subject 4 only, 
the fourth TEeff point was discarded, due to significant bulk head motion. 
T2 values from both QUIXOTIC analyses were then calibrated to Yv using curves 
generated with empirical data and theoretical relationships (60,108) and van Zijl and 
Clingman (personal communication) incorporating the hematocrit measured from the 
volunteer.  Since QUIXOTIC data considers blood mostly from small vessels, calibration 
curves were calculated using microvascular hematocrit (i.e. by multiplying the measured 
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hematocrit by 0.85) to properly correct for hematocrit differences between small and large 
vessels (77)).  Ya was taken as the oxygen saturation measured with the pulse oximeter; 
equation [15] then calculated OEF.   
To calculate CMRO2 from equation [16], an additional CBF measurement was made 
using ASL MRI, with a QUIXOTIC-matching slice prescription.  ASL data were similarly 
analyzed to generate blood-flow-weighted images, by subtracting, motion correcting, and 
averaging.  These images were calibrated to absolute CBF maps by using the local tissue 
proton density provided by the M0 scan; details of the calibration process are described in 
(79).  With this additional CBF measurement and by using hematocrit to estimate [Hbtotal], 
CMRO2 was estimated.  Finally, CMR was calculated by taking the ratio of ∆CMRO2 to 
∆ETCO2, during hypercapnia challenge.  
All data processing was done in Neurolens (www.neurolens.org) software and with 
custom Matlab (Mathworks, Natick, MA) routines. 
4.4 Results 
Average change in ETCO2 was 6.1 ± 0.8 mmHg.  Using the aforementioned gas delivery 
apparatus, we were able to keep ETCO2 quite constant during the hypercapnic challenge.  
Since inspired O2 fraction only marginally changed as the subject switched between 
compressed air and the CO2/air mixture, arterial O2 saturation did not measurably change (Ya 
= 0.98 or 0.99 for all subjects).    
Figure 4-1a shows the mean difference images for the venular-targeted acquisition 
during normocapnia and during hypercapnia for a representative subject, all equally 
windowed.   The signal in these images ideally represents post-capillary venular blood and 
thus decays with a T2 time constant related to degree of oxygenation.   Figure 4-1b show the 
ASL-CBF maps for both normocapnia and hypercapnia.   
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Figure 4-1.  QUIXOTIC data from subject 1 during normocapnia and hypercapnia.  Venular-blood weighted 
maps at different effective echo times (a) during normocapnia (top row) and hypercapnia (bottom row).  CBF 
maps (b) during normocapnia (top) and hypercapnia (bottom). 
Qualitatively, a few differences are immediately observed.  In Figure 4-1a, venular-blood 
maps images acquired during hypercapnia have considerably slower GM signal intensity (SI) 
decay across the TEs compared to those acquired during normocapnia.  This phenomenon 
suggests longer T2 in hypercapnia, and thus higher venular oxygen saturation. CBF increase 
during hypercapnia is also immediately apparent as told by the increased SI in the Figure 
4-1b ASL-CBF map.    
Figure 4-2 displays the slice orientation of the preceding acquisitions, overlaid on a high 
resolution mid-sagittal section from the MP-RAGE.   For all subjects, the prescribed slice was 
superior to the corpus callosum, thus containing mostly gray and white matter (WM), with 
little ventricular CSF contribution.    
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Figure 4-2. Representative anatomical MP-RAGE from subject 1 with overlay of prescribed slice. 
Figure 4-3 plots venular-blood SI against TEeff for subject 1 on a semilog scale.  The data 
are fitted with a single exponential function to solve for venular-blood T2; T2 for subject 1 
increased from 82 ms during normocapnia to 114 ms during hypercapnic.  This is visually 
represented by the dramatic difference in slope between noromocapnia and hypercapnia fit 
curves; the shallower slope represents slower T2 relaxation of venular-blood.   
 
Figure 4-3.  Representative log(Signal Intensity) versus TEeff, and corresponding T2 fits during normocapnia 
(blue) and hypercapnia (red) for subject 1. 
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Venular-blood T2 values are calibrated to venular blood oxygen saturation (Yv) using the 
calibration curve in Figure 4-4, resulting in Yv = 0.75 during normocapnia, and Yv = 0.85 
during hypercapnia.  Intercepts for normocapnia and hypercapnia are shown to highlight 
changes between the two states.  
 
Figure 4-4. Representative T2 versus blood oxygen saturation (Y) curve used for normocapnia (blue) and 
hypercapnia (red) calibration for subject 1.   
Complete results are displayed in Table 3, which summarizes parameters across all four 
subjects for normocapnic and hypercapnic states; T2, Yv, OEF, CBF, CMRO2, and ETCO2 for 
cortical GM are presented.  It was found that cortical GM Yv and CBF increased by 17 ± 6% 
and 33 ± 9%, respectively, while OEF and CMRO2 decreased by 44 ± 13% and 26 ± 14%, 
respectively.   
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Table 3. Summary of  T2,  CBF,  Yv, OEF, and CMRO2 during normocapnia and hypercapnia 
Subj  T2 
% 
change CBF 
% 
change
Yv 
% 
change
OEF % 
change CMRO2 
% 
change
1 Normo 82 67 0.72 0.27 164 
  Hyper 102 
26 
85 
27
0.80
10
0.19
-28 
 150 
-8
2 Normo 82 53 0.75 0.24 137 
  Hyper 114 
39 
70 
32
0.85
13
0.14
-41 
 107 
-22
3 Normo 78 65 0.68 0.31 156 
  Hyper 124 
58 
84 
28
0.85
23
0.15
-53 
 94 
-39
4 Normo 80 46 0.72 0.27 114 
  Hyper 127 
58 
67 
47
0.87
21
0.12
-55 
 75 
-34
Mean Normo 81 58 0.72 0.27 143 
  Hyper 117 
45 
77 
33
0.84
17
0.15
-44 
107 
-26
 
Table 4 summarizes ∆CMRO2, ∆ETCO2, and CMR:   
Table 4.  Cebrabral Metabolic Reserve (CMR) 
Subject ȴCMRO2 ȴETCO2 CMR 
1 -14 7.0 -2.0 
2 -30 6.0 -5.0 
3 -62 6.0 -10.3 
4 -39 5.5 -7.1 
Mean -36 6.1 -6.1 
Std Dev 20 0.6 3.5 
 
Figure 4-5 plots OEF and CBF for all four subjects, during normocapnia and hypercapnia.  
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Figure 4-5.  Changes in OEF (a) and CBF (b) from normocapnia to hypercapnia.  Changes between the two 
states are significantly significant (paired t-test, p < 0.05).   
Figure 4-6 plots CMRO2 and ∆CMRO2; clearly marked is the 95% confidence interval for 
true ∆CMRO2.  
 
Figure 4-6.  Before-after plot summarizing changes in CMRO2 from normocapnia to hypercapnia (a) and 
∆CMRO2 plot (b) for all subjects.  The CMRO2 decrease is statistically significant (paired t-test, p < 0.05).  The 
95% confidence interval for true ∆CMRO2 is indicated on (b).   
 A paired t-test done on the Yv, CBF, and CMRO2 data shows a significant difference 
between normocapnia and hypercapnia for all three parameters, at p = 0.01, p = 0.0003, and 
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p = 0.036, respectively.  In sum, cortical Yv and CBF show statistically significant increases 
during hypercapnia, while cortical CMRO2 shows a statistically significant decrease during 
hypercapnia.   
4.5 Discussion 
In this study, a recently developed MRI technique called QUantitative Imaging of the 
eXtraction of Oxygen and Tissue Consumption, or QUIXOTIC, was used to assess cortical 
CMRO2 in awake humans during mild hypercapnia challenge.  It was found that cortical 
CMRO2 markedly decreases in response to hypercapnia, resulting from a pronounced OEF 
reduction compared to a modest CBF increase.   
To our knowledge, this is the first time cortical GM CMRO2 in awake humans has been 
evaluated in response to hypercapnia, a capability enabled by the QUIXOTIC technique.  GM 
has by far the highest density of neural cell bodies in the brain, and as such houses the vast 
majority of neuronal signaling, energy consumption, and cerebral blood flow (109).  As a 
consequence, ∆CMRO2 from these regions may be more informative than global measures 
that include WM.  It is expected that WM would exhibit smaller response magnitudes, since 
it is predominantly made up of myelinated axon tracts, as opposed to neuronal and glial cell 
bodies (109).  We thus believe that global CMRO2 measures will underestimate CO2 
sensitivity, and expect to best capture neuronal and glial metabolic response by considering 
CMRO2 exclusively in GM regions. 
CMRO2 depression during hypercapnia is consistent with at least two recent studies 
(45,46) and several older studies (110-112), but is at odds with studies that report 1) no 
change in CMRO2 during hypercapnia (e.g.(103,106)), and 2) CMRO2 increase during 
hypercapnia (e.g. (42,105)).  Several possible explanations exist for these variable 
observations, most of which are likely based on heterogeneous study design.  For one, 
aforementioned studies were performed in many different species under several states of 
consciousness (e.g. anesthetized versus awake), measured different aspects of 
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neurophysiology (e.g. neuronal activity versus cellular metabolism), used different 
experimental modalities (e.g. MRI versus electrophysiology), and induced different levels of 
hypercapnia.  Contradictory observations are therefore not surprising; state of 
consciousness alone will affect results, since anesthesia alters coupling relationships 
between neural, metabolic, and vascular parameters which may in turn alter hypercapnia 
response (48,113). 
Because of the significant heterogeneity in experimental procedures and results, we 
restrict our comparison to consider only the study most closely related to ours: a TRUST-
based (T2-relaxation-under-spin-tagging) approach presented by Xu and colleagues (45).  This 
study is similar to our QUIXOTIC-based method in three principal ways:  it 1) uses an 
intravascular T2-based approach first measure Yv and OEF, 2) uses Fick’s Laws to calculate 
CMRO2 from CBF and OEF via equations [15] and [16], and 3) considers awake human 
subjects under similar levels of hypercapnia.  
While we report an average 26 ± 14% reduction in cortical CMRO2 via QUIXOTIC, Xu et 
al. report a smaller global decrease of 13% using their TRUST-based methods.  This 
divergence is further magnified considering that the degree of hypercapnia induced in the Xu 
study is slightly higher than that induced here (i.e. mean ∆ETCO2 = 8.7 mmHg and 6.0 mmHg, 
respectively), and in fact produces a 44% CBF increase compared to the 33% increase in this 
study.  If CMRO2 depression is similarly dose-dependent, a CMRO2 reduction even less than 
13% is expected (given a 5-7 mmHg ETCO2 challenge).  We posit two explanations for the 
discrepancy.  First off, for a variety of possible reasons (114), baseline OEF measurements 
with QUIXOTIC are on average ~15% lower than baseline TRUST OEF measurements.  
Consequently, for an identical absolute decrease in OEF, the percentage decrease in OEF will 
be much larger.  This in turn translates to a much larger decrease in CMRO2.  Interestingly, 
however, absolute OEF decreases per mmHg ETCO2 are 2.0 ·10
-2 mmHg-1 and 1.8 ·10-2 
mmHg-1 for QUIXOTIC and TRUST, respectively, suggesting consistency in ∆OEF during 
hypercapnia, if not consistency in %CMRO2 decrease.  In this light, systematic baseline 
differences between QUIXTOIC and TRUST may account for the observed variability. 
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An additional source of discrepancy may arise from the fact that QUIXOTIC results 
reflect CMRO2 changes in cortical GM only, whereas values provided by TRUST represent 
average CMRO2 across GM and WM.  As discussed earlier, because of the compositional 
differences in GM and WM, CMRO2 response to hypercapnia may be different across GM 
and WM compartments, and likely smaller in WM due to fewer neuronal and glial cell 
bodies.  Since TRUST reports a mixture of both WM and GM response, the lower reduction in 
CMRO2 could simply be due to this response averaging.  From this point of view, our results 
are not necessarily inconsistent with those reported by TRUST methodology.    
Several mechanisms may explain hypercapnia-induced CMRO2 reduction.  An immediate 
consequence of elevated CO2 is decreased pH, since CO2 binds with water to form carbonic 
acid.  Decreased pH has previously been shown to reduce energy metabolism (115) and 
decrease neuronal activity (by blocking an excitatory currents) (116).  Apart from pH-
mediated changes, CO2 may directly affect the cellular membrane, also resulting in signal 
cascades ultimately leading to decrease in neuronal activity (112).  Assuming coupling 
between neuronal activity and CMRO2 (117,118), decreases in neuronal activity will translate 
into decreases in CMRO2.  Finally, under the recently posed hemo-neural hypothesis, the 
large hypercapnic CBF increase could modify neural activity and/or CMRO2, through direct 
and indirect mechanisms (119). 
Unintended sensory stimulation resulting from hyercapnia could also alter CMRO2.  
While 7 mmHg above baseline is considered to be a mild state of hypercapnia, sensory 
stimulation does occur, especially with respects to perception of increased ventilation.  All 
subjects in this study were aware of faster and/or deeper breathing.  This perception could 
modulate neural activity and CMRO2 in an indirect fashion.  Sensory stimulation, however, is 
unlikely the source of CMRO2 depression for three reasons:  1) as seen in figure 2, the slice of 
interest does not contain primary or secondary respiratory areas of the brain, 2) respiratory 
centers would be expected to increase neural activity from stimulation, not decrease activity 
(120), and 3) the CMRO2 decrease is widespread across the cortex and not isolated to a 
specific cortical processing center. This can be seen qualitatively in Figure 4-1; CBF and Yv 
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effects leading to decreased CMRO2 occur throughout cortical GM, and are not confined to a 
specific region. 
Finally, since the CMRO2 reduction in this study results from a pronounced OEF 
reduction (1.8x) compared to a modest CBF increase (1.3x), the accuracy of the CBF 
measurement must also be scrutinized.  We report an average 33% increase in CBF during 
hypercapnia in response to an average 6.1 mmHg increase in ETCO2, or 5.4% mmHg
-1.  This 
value is consistent with at least two other studies which report increases of 28.7% and 30.8% 
in response to average ∆ETCO2 of 6.3 mmHg and 5.7 mmHg respectively, resulting in 4.5% 
mmHg-1 and 5.4% mmHg-1 (121,122).  Consequently, the observed CMRO2 depression is 
unlikely to due an error in CBF estimation.   
4.5.1 Implications for CO2 BOLD MR imaging 
CMRO2 reduction is consistent with the large BOLD increases frequently observed during 
hypercapnia, and in fact is likely a contributing factor.  While the primary driver of the 
hypercapnic BOLD signal is increased CBF flushing out signal-dephasing deoxyhemoglobin, 
CMRO2 reduction will result in less oxygen extracted from blood, also reducing 
deoxyhemoglobin.  Decreased CMRO2 has an additive effect with increased CBF, and further 
increases the BOLD signal.  
This result has important implications with regards to the calibrated BOLD approach.  As 
previously mentioned, hypercapnic calibration is required to properly normalize BOLD and 
CBF signals, and subsequently tease out relative CMRO2 time courses.  However this process 
assumes that the hypercapnic BOLD signal is independent of CMRO2; an assumption not 
supported by these results.  As a consequence, hypercapnic BOLD calibration may result in 
erroneous estimates of relative CMRO2, and consequently confound flow-metabolism 
relationships.  Further studies are warranted to more deeply investigate how these changes 
in CMRO2 during hypercapnia will affect calibrated BOLD studies. 
By similar reasoning, CMRO2 depression will alter vascular reserve measurements in 
settings of stroke, cerebral ischemia, and carotid artery stenosis.  Most approaches for 
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evaluating CVR use a CO2 BOLD procedure and, like calibrated BOLD methods, contend that 
changes in hypercapnic BOLD response are purely vascular.  However, because of CMRO2 
depression, the measured hypercapnic BOLD response will be slightly larger than a purely 
vascular BOLD response.  The subsequent overestimate of CVR could lead to incorrect and 
potentially dangerous conclusions; for example, a patient at increased risk for stroke or TIA 
may be overlooked because of an artificially inflated CVR.    
4.5.2 Cerebral metabolic reserve (CMR) 
Despite complicating some applications of hypercapnia, CMRO2 depression holds interesting 
possibilities.  Similar to how perturbations in global CBF allow CVR characterization, a 
QUIXOTIC CO2 approach could be used to measure ∆CMRO2 to ∆ETCO2, and establish a 
cerebral metabolic reserve (CMR) parameter.  Qualitatively, CMR will be related to the 
extent CMRO2 can decrease without functional impairment, which may have important 
clinical implications.  While it is known that CMRO2 can decrease substantially without 
adverse effect (for example, during stage one, non-REM sleep), the margin of decrease may 
be altered in early disease states.  In stroke, for example, abnormal CMR may help identify 
and delineate penumbric tissue (i.e. tissue at high risk of infarction, but still viable).  In tumor 
settings, CMR status could conceivably affect radiotherapy efficacy, in addition to or 
independent of oxygen status.  Because of the large heterogeneity in oxygen status and 
outcome, identifying new markers like CMR to evaluate oxygen-modifying strategies will be 
invaluable (101). To better gauge the utility of CMR more generally, we suggest 
characterization in both healthy subjects and patients, followed by correlation analysis to 
associate CMR with specific outcomes. Such information could be used to identify 
candidates who will benefit from specific interventions and therapies, and those who may 
have negative reactions. CMR provides unique information via CMRO2 response, not 
captured by baseline CMRO2 alone; we contend that abnormal CMR may even be an early 
indicator of metabolic dysfunction, before baseline CMRO2 is affected.  For these many 
reasons, we believe that CMR will provide independent, unique, and clinically relevant 
information.   
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4.5.3 Neuroprotection  
A particularly interesting consequence of CMRO2 reduction by hypercapnia, is the possibility 
to use CO2 as a neuroprotective agent.  It has long been established that alleviating brain 
injury could be facilitated by decreasing cerebral metabolic requirements, and it is 
postulated that known neurprotective agents like barbiturates and isofluorane may in fact 
exert their effects by reducing CMRO2 (123).  In this light, CO2 administration may aid in 
mitigating brain injury and concurrently increase CBF to ischemic areas.  Additionally, since 
neurological injury may occur during anesthesia and surgery, CO2 could also be administered 
as prophylactic measure. Further studies are necessary to examine the efficacy of CO2-
mediated CMRO2 depression for brain protection. 
4.5.4 Methodological extensions of CO2 QUIXOTIC 
Due to signal-to-noise ratio (SNR) considerations, this current was study was restricted to a 
single hypercapnic perturbation.  However, a more detailed study is warranted to better 
understand effects of hypercapnia on GM CMRO2.  A newly introduced multiecho 
implementation of QUIXOTIC allows collection of many echoes during a single scan (instead 
of one TEeff per scan), which will result in a many-fold decrease in imaging time and 
significant reduction in sensitivity to physiological noise and motion.  Additionally, the 
QUIXOTIC technique can easily be extended to higher magnetic field strengths, which will 
increase SNR by means of increased magnetization and longer T1 decay, also permitting scan 
time reduction.    
With the above improvements, a more complete assessment of CMRO2 during 
hypercapnic challenge will be possible.  Graded hypercapnia will tease out dose-dependent 
CMRO2-CO2 relationships.  This will help determine whether eliminating sensory perception 
of increased ventilation (by reducing ∆ETCO2) will eliminate CMRO2 depression, and if so, 
whether such levels of CO2 will still cause a ∆CBF large enough for CVR evaluation and BOLD 
calibration.   
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4.6 Conclusion 
We have successfully shown that QUIXOTIC MRI can be used to ascertain changes in cortical 
gray matter CMRO2 during CO2 challenges in awake humans.  Cortical CMRO2 was found 
substantially reduced in response to a mild hypercapnic challenge, which has important 
implications for studies using hypercapnia to measure cerebral vascular reserve, modify 
tumor hypoxia, and calibrate the BOLD signal.  CO2-challenge offers a safe and easy way to 
globally and reversibly depress CMRO2, thereby allowing the characterization of a new 
parameter called cerebral metabolic reserve (CMR).  We postulate that CMR indicates how 
far CMRO2 can drop before functional impairment, and may help identify regions of impaired 
CMRO2-response, with intact baseline CMRO2.  Finally, CO2-mediated CMRO2 depression 
may offer a new approach for protecting against brain injury.  Future studies will look at 
CMRO2 response at several levels of hypercapnia and establish a normal range of CMR, 
which may be useful in a variety of functional and clinical scenarios. 
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Chapter 5  
Ongoing studies 
5.1 Feasibility of QUIXOTIC to assess functional changes in venular 
oxygen saturation during visual stimulus 
5.1.1 Introduction   
As discussed in Chapter 1, absolute CMRO2 may offer tangible advantages over BOLD 
imaging in assaying evoked changes in neuronal activity.  Before specific comparisons can be 
made, it is necessary to perform prototypical functional experiments to assess general 
feasibility for using QUIXOTIC for fMRI.   
The simplest fMRI paradigm is the so-called “block” or “epoch-related” design, which 
interleaves stimulus ON periods with stimulus OFF periods.  Images are acquired with high 
temporal resolution (i.e. one every few seconds) for the duration of the paradigm.  A general 
linear model is created by convolving the stimulus design with an estimated response 
function; the model is then fit to the time series data and a t-statistic map is generated, 
highlighting areas that have statistically different signal during the OFF periods (baseline) 
compared to ON periods (activation).  In this way, regions that respond to the stimulus can 
be robustly identified.   
A T2-preparation-based QUIXOTIC approach can be used in this manner to assess 
functional changes in OEF and CMRO2, but requires several repetitions of the trial (as 
opposed to single trial, which is sufficient for BOLD imaging).  Multiple VT-VSSL acquisitions 
are required to generate venular-blood maps at successive TEeffs; at the absolute minimum, 
scans at two Teffs are required for a T2 fit.  Additionally, a CBF trial must also be acquired for 
final CMRO2 calculation.  For these reasons, a simple block design QUIXOTIC experiment may 
still be quite long.  
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Due to this time requirement, this preliminary application of QUIXOTIC fMRI omits the 
CBF scan and focuses on measuring Yv and OEF with only two VT-VSSL scans.  This decreases 
scan time and exposure to the fMRI stimulus by one-third, making the experiment more 
comfortable for the subject.  Additionally, Yv and OEF alone may have unique importance 
with respect to the BOLD signal.  Recently, Lu and colleagues (22) have shown that baseline 
venous blood oxygen saturation modulates the BOLD response amplitude in a predictable 
way, thus providing a physiologic explanation for high BOLD variability.  These observations 
suggest that an fMRI technique able to directly evaluate functional changes in absolute Yv 
may be a more repeatable and physiologically relevant way to assess neuronal activation. 
QUIXOTIC was therefore used to assess functional changes in Yv and OEF during a 
prototypical visual stimulus task: full-field flashing checkerboard.  Regions that significantly 
modulate Yv and OEF during stimulation are indentified, and absolute values during baseline 
and activation are reported.  
5.1.2 Methods 
A single healthy human volunteer was scanned (male, aged 25) at 3T (Siemens Tim Trio, 32-
channel head coil).  A block design visual stimulus was used to modulate neuronal activity in 
the visual cortex. The stimulus consisted of two minute presentations of an 8 Hz flashing 
radial checkerboard (with central fixation point), interleaved with two minutes of the 
fixation point alone, for a total of 10 minutes (i.e. 3 OFF epochs and 2 ON epochs).  The 
paradigm is illustrated in Figure 5-1.   
 
Figure 5-1.  Block design visual stimulus task 
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Subjects were instructed to gaze at the fixation point for the duration of the scan.  
During this time, a QUIXOTIC pulse sequence equipped with a GRE-EPI readout was used to 
acquire a time series data set.  The functional experiment was performed twice, once with 
TEeff = 20 ms and once with TEeff= 60 ms. A dual-echo approach enables T2 measurement of 
the venous-targeted blood pool and subsequent Yv estimation. QUIXOTIC scan parameters 
were VCUTOFF = 2.1 cm/s, TO = 725 ms, TEeff = 20/60 ms and GRE-EPI parameters were TE/TR = 
12/3000 ms, single slice, 3.9x3.9x10 mm3.  Raw time series data were smoothed and motion 
corrected.  A sequence of venous-blood-weighted images was generated by pairwise 
subtraction of successive tag and control images. Functional analysis was performed by 
fitting a linear signal model to the venous-blood-weighted series. The model consisted of 
regressors representing the block design stimulus, a linear drift term, and a constant (DC) 
term. Maps of t-statistic were subsequently generated for each TEeff acquisition; a voxel was 
considered activated if its t-statistic value was above a threshold corresponding to p = 0.005. 
Activated voxels common to both experiments were used to create a common region of 
interest (ROI). 
Averaging the time course of all voxels within this ROI generates a mean activation time 
course, one for each TEeff acquisition.  ɴ coefficient values from the linear model fit to these 
mean time courses were used for T2 measurement. ɴDC, representing the baseline signal, and 
(ɴDC + ɴEFFECT), representing the signal during activation, were plotted against TEeff and fit 
with a single exponential to estimate basline T2 and activated T2, respectively. These T2 
values were then converted to Yv using the T2 versus Y calibration curve presented in section 
2.3.   
5.1.3 Preliminary results  
The activation maps revealed significant changes in venous-blood-weighted signal during the 
checkerboard presentation.  Figure 5-2a shows representative EPI images overlaid with the 
QUIXOTIC activation ROI containing voxels activated in both functional runs.  
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Figure 5-2b shows the corresponding functional time course for the activated region (linear 
drift term removed) for the TEeff = 20 ms run; ɴDC and ɴEFFECT are labeled.  
 
Figure 5-2.  Activation ROI overlaid on raw QUIXOTIC image (a) and activation ROI time course overlaid with 
model fit (b). 
Figure 5-3 plots ɴDC and (ɴDC + ɴEFFECT) versus TEeff and the corresponding T2,BASE and T2,ACT fit 
curves.  
 
Figure 5-3.  ɴDC and ɴEFFECT versus TEEFF and baseline/ activation T2 fits 
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Table 5 summarizes T2 , Yv, and OEF results from the human subject. Significant changes in 
absolute Yv and OEF during visual stimulus are observed.  
Table 5.  QUIXOTIC Yv results during functional challenge 
  Baseline  Activation Difference
T2 (ms) 69 112 43 
Yv 0.67 0.81 0.14 
OEF 0.33 0.19 -0.14 
 
5.1.4 Discussion 
The reported values for ȴYv are comparable to those found in (39) and (62), but are slightly 
lower that those reported by others in (63) and (53). This may be due to inclusion of blood 
from veins draining from unactivated regions, which will dilute the overall oxygen 
concentration in the activated blood pool, biasing T2,ACT (and subsequently Yv,ACT) towards 
the baseline level.  To avoid this problem, venous oxygen saturation should be measured 
only in venules immediately distal to sites of neuronal activation. To exclusively target blood 
in these small vessels, future studies will employ so-called “Velocity Bracketed” QUIXOTIC, 
which will be discussed in section 6.2.2.   
5.2 Turbo QUIXOTIC:  a multi-echo variant of QUIXOTIC 
5.2.1 Introduction 
One of the major limitations of T2-preparation-based QUIXOTIC is the necessity to acquire 
VT-VSSL scans at successive TEeffs for T2 fitting.   As seen in the previous section, a minimum 
of two TEeff scans are necessary to estimate T2; additional data points, however, will make 
the technique more resistant to noise, motion, and other sources of error, and thereby 
improve accuracy.   Acquiring data at multiple TEeffs, however, is extremely time-consuming.  
Between twenty and thirty minutes of scan time (not including the additional CBF scan) is 
required for as few as five or six TEeff points, essentially precluding QUIXOTIC for any clinical 
setting.  Block-designed fMRI studies are also limited by the single-TEeff-per-scan 
implementation; the paradigm must be repeated at least three times (twice for VT-VSSL at 
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two distinct TEeffs and once for ASL-CBF) to complete the full Yv, OEF, and CMRO2 QUIXOTIC 
acquisition.  Furthermore, since TEeffs are acquired in separate scans, there is a loss of 
continuity; bulk motion or scanner drift across measurements may cause minor spatial shifts 
in voxel signal, resulting in misalignment from TEeff to TEeff.   
Ideally, all TEeffs should be collected on a measurement by measurement basis.  In 
addition to a gain in robustness, obtaining all TEeffs per measurement will decrease total scan 
time several-fold, making the technique practical for numerous applications.  
5.2.2 Theory and methods 
To allow for this improvement, the T2-preparation is abandoned and the GRE-EPI readout is 
replaced with a turbo spin echo (TSE) readout, as shown Figure 5-4.   
 
Figure 5-4.  Modified QUIXOTIC sequence with TSE readout 
With this new scheme, a full EPI readout is acquired after every 180° refocusing pulse (of 
note, the same adiabatic refocusing pulses previously used for the VS modules are used) to 
generate images of a single slice at multiple echo times.  The major challenge, however, is 
optimize the EPI module such that the echo spacing (or equivalently ∆TE) remains 
approximately equivalent to τ used in the T2-preparation version of QUIXOTIC.  This is 
necessary since the empirical data used to generate T2 versus Y calibration curves was 
acquired using a specific τ of 10 ms.  Significant deviation from this τ value will change the 
relationship between T2 and Y (due to water exchange between red blood cells and plasma), 
and invalidate the calibration step.  Additionally, as ∆TE increases beyond τ, fewer TEeff 
images can be acquired before the venular-blood maps decays into noise.   
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Using available hardware and non-parallel signal reception, the shortest acquisition 
possible is approximately 25 ms, thus limiting ∆TE to about 30 ms -- considerably longer than 
desired.  To circumvent this limitation, parallel imaging methods are employed.  Parallel 
imaging accelerates image acquisition significantly by exploiting the multi-channel reception 
of the 32-channel imaging coil.  A specific parallel imaging method known as GRAPPA (124) is 
employed and reduces the EPI readout acquisition time to roughly 8 ms (i.e. an acceleration 
factor of 3x), allowing a ∆TE of 12.6 ms – much closer to the desired 10 ms.    
To test this sequence, a single subject was scanned (male, 32 years) at 3T (Siemens Tim 
Trio, Erlangen, Germany) with the 32-channel head coil, using a similar control –tag 
acquisition strategy.  In sharp contrast to the previous VT-VSSL acquisitions, only a single 
scan was acquired, with a five echo TSE train.  The VT-VSSL imaging parameters were as 
follows:   VCUTOFF = 2.1 cm/s (G = 1.60, D = 17.5 ms, δ = 2 ms, x-directed velocity 
weighting), ∆TEeff = 12.6 ms, matrix size = 64x64, voxel size 3.9x3.9x10 mm3, PPF = 6/8, TO = 
725 ms,, TR = 5s s, 60 measurements, scan time = 5 min).  An additional double inversion 
recovery (DIR) sequence was used to acquire cortical GM only images, with identical slice 
orientation (TI1 = 3700 ms, TI2 = 4280 ms, one measurement, other parameters identical to 
those above).  
Analysis of VT-VSSL data consisted of motion correcting, subtracting, and averaging to 
create images at each TEeffs.  Cortical GM was segmented using the DIR mask, and mean 
venular-blood signal intensity from contained voxels was plotted versus TEeff and fit for T2.   
5.2.3 Preliminary results 
Figure 5-5 presents VT-VSSL images at five TEeffs acquired with the Turbo QUIXOTIC pulse 
train.  Slight asymmetric signal intensity enhancement is observed on the left side of the 
brain image (anatomical right), but is not as pronounced on the right side.  Figure 5-6 depicts 
mean cortical GM SI versus TEeff data, with the T2 fit curve.  An excellent goodness-of-fit is 
observed. 
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Figure 5-5.  Mean venular blood maps at five TEeffs acquired with turbo QUIXOTIC methodology. 
 
Figure 5-6.  Mean cortical GM SI versus TEeff and corresponding T2 fit. 
5.2.4 Discussion 
Despite the minor artifacts in the VT-VSSL images, these preliminary turbo QUIXOTIC data 
are very promising.  The measured T2 of 82.3 ms is comparable to those measured in the 
study presented in Chapter 3 (mean ± SD = 87 ± 4); the fit quality is in fact superior (R2 = 
0.994).   
One potential issue in this TSE implementation of VT-VSSL, is that TEeff images are 
generated after each adiabatic refocusing pulse.  A single adiabatic pulse, however, will 
impart a nonlinear phase across the excitation bandwidth, which can manifest in the final 
image as an artifact.  This nonlinear phase, however, will be perfectly compensated by the 
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next adiabatic pulse (66).  In this way, a slight mismatch between images at even and odd 
TEeffs will occur, and in fact can be appreciated by looking closely at Figure 5-6.  Fortunately, 
the variation is quite small and does not considerably affect the overall quality of the fit.  
Future implementations will examine this phenomenon more rigorously and may 
incorporate newer RF pulse strategies to mitigate the effect.   
As witnessed, turbo QUIXOTIC offers an substantial boost in imaging speed.  The 
equivalent experiment using T2-prepared VT-VSSL to acquire images at five TEeffs would take 
approximately 27 minutes, which is 500% longer than this experiment.  Two potential 
drawbacks, however, arise when using the technique:   
1. The sequence is no longer perfectly insensitive to flow effects.  Images at subsequent 
TEeffs will experience ∆TEeff = 12.6 ms worth of additional flow.  In this way, the 
measured T2 will not uniquely represent venous oxygenation saturation, but will be 
slightly increased by the additional imaging spins at each successive TEeff.  This 
confounding effect, however, is expected to be small given typical QUIXOTIC cutoff 
velocities of 2 cm/s and a ∆TEeff of 12.6 ms.  Additional work is necessary to 
guarantee that this is indeed the case.         
2. Given the same amount of measurements the image SNR at a given TEeff will be lower 
in turbo QUIXOTIC compared to standard T2-prepared QUIXOTIC.  Since SNR scales 
with imaging readout time, this is an unavoidable side effect of shortening the EPI 
readout via parallel imaging.  However, this is not a serious concern for two reasons: 
a) given the drastically shorter nominal imaging time, the actual imaging time can be 
lengthened to increase SNR, and b) for reasons discussed above, higher quality fits 
are possible with all echoes acquired within a single measurement. Consequently, the 
minimum SNR required for reasonable fits is expected in turbo QUIXOTIC is expected 
to be less than required in T2-prepared QUIXOTIC.  
By decreasing imaging time, turbo QUIXOTIC offers a methodological improvement over 
traditional QUIXOTIC and makes the technique practical in both clinical and fMRI settings.  
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Furthermore, also because of the drastic reduction in scan time, turbo QUIXOTIC will allow 
comprehensive characterization of VCUTOFF, TO, and other parameters, and ultimately help 
determine an optimal parameter set for accurate, high SNR QUIXOTIC application.   
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Chapter 6  
Conclusions & Future Work  
6.1 Conclusions 
Due to the fundamental nature of CMRO2 with regards to brain health and function, 
quantitative CMRO2 imaging methods are highly sought after in both clinical and basic 
neuroscience settings.  Many brain pathologies will affect CMRO2; as such, detailed 
quantitative knowledge will assuredly be useful to improve diagnosis, evaluate new 
therapies, and monitor disease progression.  From a neuroscience perspective, measuring 
CMRO2 in response to task-based stimulation should enable new advances in understanding 
and functional architecture and connectivity, due to its close relationship to underlying 
neuronal activity.   
This dissertation presents a novel method for imaging OEF and CMRO2 dubbed 
QUIXOTIC.  Fundamental QUIXOTIC theory has been described, strength and limitations 
analyzed and discussed, and results from initial applications presented. To our knowledge, 
QUIXOTIC is the only technique that offers all of the four following features: 
1. Generation of pure venular blood maps (via velocity selective spin labeling). 
2. Voxel-by-voxel OEF & CMRO2 quantification. 
3. Amenability to typical epoch- and event-related fMRI (since images are generated 
every 2ƒTR). 
4. Insensitivity to non-dHb field variations (since extravascular tissue signal is 
subtracted).  
The specific contributions of this thesis are following: 
• Introduction of novel QUIXOTIC method, including fundamental theory and 
elaboration of properties with respect to key VCUTOFF and TO parameters. 
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• Application of QUIXOTIC in healthy humans to measure Yv, OEF, and CMRO2 for 
validation and comparison to an existing global method. 
• Application of QUIXOTIC in awake humans to assess changes in CMRO2 during CO2 
challenge. 
• Preliminary investigations in assessing feasibility of QUIXOTIC to measure Yv  and OEF 
in a prototypical fMRI experiment. 
• Preliminary investigations in substantially accelerating QUIXOTIC via TSE-based turbo 
QUIXOTIC. 
6.2 Future work 
Before widespread use of QUIXOTIC can be realized, several properties of the approach 
deserve further study, especially with regards to accuracy and potential sources of bias.  
Being in its infancy, QUIXOTIC can be extended in several directions: 
6.2.1 Exploration of bias sources and QUIXOTIC parameter space  
The discrepancy in Yv values between TRUST and QUIXOTIC introduced in Chapter 3 is a 
logical starting point for further study.  It is not clear whether the inconsistency is due to 
oxygenation differences in early venular blood versus terminal venous blood, or due to a 
systematic bias of the technique.  The confounding sources described in Chapter 3 require 
in-depth characterization; if one of them ends up being a material source of bias, it could be 
addressed with appropriate refinements or adjustments of QUIXOTC, followed by further 
validation study.   
A task that could yield further improvements is a systematic exploration of the VCUTOFF 
and TO parameter space – an endeavor not yet performed because of the currently long 
imaging time of T2-prepared QUIXOTIC.  Fortunately, I expect advances in turbo QUIXOTIC to 
overcome the practical limitations of  this parameter evaluation in human subjects, and 
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expect to gain further understanding of the QUIXOTIC technique in general, and allow 
parameter optimization for robust performance in a variety of applications.  
6.2.2 Velocity bracketing 
An additional modification to the QUIXOTIC design is modification called “Velocity 
Bracketing.”  Velocity Bracketing imposes a different VCUTOFF for the control VS2 module 
(which in this initial investigation was simply VCUTOFF = infinity) that is larger than the tag VS2 
VCUTOFF.  The trailing edge of the bolus remains defined by the tag VS2 VCUTOFF , while the 
leading edge will be now defined by this new larger control VS2 VCUTOFF, termed VBRACKET.   By 
introducing this additional VBRACKET design parameter, the final subtracted bolus is now 
bracketed by these two velocity cutoffs and will be limited to blood within the specified 
velocity bracket.  
This application of Velocity Bracketing allows TO optimization to maximize imaging spin 
volume and SNR without a sacrifice in spatial specificity via spin clearance (a phenomenon 
described in section 2.1.2.1).  At the same time, imposing velocity selection for the control 
VS2 is expected to decrease diffusion contribution from tissue or CSF in the final subtraction 
images, since the control-imposed diffusion and tag-imposed diffusion will be more similar 
than without Velocity Bracketing.  The Velocity Bracketing refinement to QUIXOTIC offers 
additional flexibility to the technique, and will be investigated in future research.   
6.2.3 QUIXOTIC at higher field strengths 
Like all spin-labeling based technologies, SNR is arguably the most severe limitation of 
QUIXOTIC.  Long imaging times are required to generate images at conventional 1.5T and 
3.0T field strengths.  At current SNR-levels, voxel-by-voxel T2, OEF, and CMRO2 analysis is not 
feasible within practical scan times, although in these characterizations lie the true power of 
the technique.  As such, extension of QUIXOTIC to higher field strengths, including 7T, will 
considerably expand the viable application window.   SNR increases with field strength due 
to an larger net magnetization, but QUIXOTIC also gains due to longer T1,blood relaxation 
constants.  QUIXOTIC imaging at higher fields is not without tradeoffs, primary among them 
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B1
+
 and B0 inhomogeneities that are more severe than at lower fields, as well as SAR 
limitations that severely restrict RF transmission.  Deoxygenated blood T2 also decreases at 
high field due to more pronounced susceptibility effects of dHb.  While considerable work 
will be necessary for QUIXOTIC at higher fields, concrete improvements in quantification and 
mapping of OEF and CMRO2 are expected that utilize emerging parallel RF excitation 
technology (125,126) to overcome the critical challenges and open up new applications 
areas for clinicians and scientists in neuroimaging.  
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